Program | ISGE 2018

Wednesday 7th March 2018

08:30 Wednesday 7th

Affari 1 Pre-Congress Course 08:30 ￫ 13:30
Menstrual cycle disorders: from adolescence to menopause

Frederick Naftolin The Hypothalamic-Pituitary-Gonadal Axis: Puberty, Menstrual Cycle Regulation, and Post-Reproductive Life
Sarah Berga Hypothalamic amenorrhea
Basil Tarlatzis Polycystic ovary syndrome
Alessandro D. Genazzani Metabolism, obesity, thinness and reproduction
Nick Panay Practical approaches to managing premature ovarian insufficiency

09:00 Wednesday 7th

Sala 226 Assembly 09:00 ￫ 11:00
FISGE Meeting

11:30 Wednesday 7th

Sala 226 Assembly 11:30 ￫ 13:30
FLEG Meeting

15:30 Wednesday 7th

Auditorium Opening Symposium 15:30 ￫ 17:00
Intracrinology: the open door to the future

Chairperson/s: David Archer , Andrea R. Genazzani

Fernand Labrie Intracrinology –the exclusive source of sex steroids in postmenopausal women is prasterone
Celine Bouchard Healthy and sex steroid-deprived vagina-from preclinical to clinical characteristics
Rossella E. Nappi The medical impact of vulvovaginal atrophy /genitourinary syndrome of menopause

17:15 Wednesday 7th

Auditorium Opening Ceremony 17:15 ￫ 18:00

The ISGE Executive Committee
Andrea R. Genazzani,
Martin Birkhaueser
Tommaso Simoncini
The Scientific Societies and Institutions
C N Purandare(FIGO) Pitfalls and limitations of current evidence generation,
John J. Sciarra(ACOG),
Mary Ann Lumsden (RCOG),
Alessandro Genazzani (AIGE)

18:00 Wednesday 7th

Auditorium Opening Lecture 18:00 ￫ 18:30
for the Bruno Lunenfeld Lecture: RANKL – from bone loss to breast cancer (introduced by Lunenfeld Bruno)

Josef M. Penninger RANKL – from bone loss to breast cancer

18:30 Wednesday 7th

Auditorium Opening Lecture 18:30 ￫ 19:00
The neurological and immunological transitions of the perimenopause: implications for post menopausal neurodegenerative disease (introduced by Frederick Naftolin)

Roberta Brinton Diaz The neurological and immunological transitions of the perimenopause: implications for post menopausal neurodegenerative disease

19:00 Wednesday 7th

Poster Area Poster Session 19:00 ￫ 21:00
From 1 To 176 See the posters that will be presented!

Jose Maria Soares Júnior P1. Evidence that melatonin increases inhibin beta-A and follistatin gene expression pinealectomized rat ovaries
ana maria Muñoz Ledesma SEVERE HYPERCALCEMIA IN PREGNANT WOMEN, SECUNDARY A NEUROENDOCRINE TUMORS
Miriam Llano P2. Different secretory pattern of melatonin in obese menopausal women: preliminary results
Rodrigo Marcondes P3. Moderate intensity treadmill exercise increases ovulation and modulates genes in the hypothalamus of adult female rats
Negina Adkhamova P4. Polymorphism C3420T of the DRD2 gene associated with menstrual flow disorder among the women with hyperprolactinemia
Ariadne Araujo P5. Gene expression of small leucine-rich proteoglycans (SLRPS) in lacrimal gland non-pregnant and pregnant with hyperprolactinemia induced metoclopramide
Natalia Garcia New therapeutic targets for uterine leiomyosarcoma: Gant61 as a blocker to non-canonical activation of Sonic Hedgehog pathway
Osvaldo Araujo Jr P6. Influence of metoclopramide-induced hiperprolactnemia on the epiphyseal plate and type of collagen in the bone tissue of female mice and their offspring after breastfeeding
Osvaldo Araujo Júnior P7. Small leucine-rich proteoglycans (slrps) on the epiphyseal plate of the female mice metoclopramide-induced hiperprolactnemia and their offspring
Irena Ilovayskaya P8. Recurrent early pregnancy loss as unusual and rare sign of pathological hyperprolactinemia
Amanpreet Kalsi P9. Macroprolactinemia: prevalence and etiopathologic associations
Berta Martín Cabrejas P10. Spontaneous pregnancy after trans-sphenoidal resection of a microadenoma refractory to medical treatment. A case report.
Felipe Serrano P11. Prolactin hyper-response is associated with incidence of herpes in patients with ovulatory dysfunction.
Larisa Suturina P12. Prevalence of hyperprolactinemia in unselected urban female population
Ana Belen Rodriguez Bujez P13. Which wil be better for the endometrium in ovarian stimulation?
Natalia Aganezova P14. Endometrial receptivity in women with a history of reproductive failures
Danijel Bursac P15. The role of GABA neurotransmitter in the regulation of the endocervical mucus secretion
Jose Maria Júnior P16. Effects of melatonin on steroidogenesis in rat ovarian theca-interstitial cells: relevance to hormone therapy in polycystic ovary syndrome (PCOS)
Lara Jessica Murao P17. A Case Report on Catamenial Epilepsy
Ricardo Ramirez Orozco P18. Role of adiposity over ERα and ERβ phosphorylation in reproductive women during ovarian cycle
Elisabetta Vegeto P19. Pharmacological regulation of estrogen receptors in macrophages: impact for the female reproductive tract
Elisabetta Vegeto P20. Sexual differences in macrophage physiology
Natasha Meletti P21. Ovarian hypertecosis and hirsutism in adolescence: case report and literature review
Marija Miletic P22. Mister XX
Cintia Mariel Villegas Rodríguez P23. Effect of hiperandrogenism on the lipid profile on women with polycystic ovary syndrome at the endocrine gynecology clinic of the hospital juárez de méxico
Peiqiong Chen P24. Association between serum level of vitamin A and premature ovarian insufficiency in women of reproductive age
Edson Ferreira Filho P25. A case of 46,XY gonadal dysgenesis with remaining epididymis mimicking ovotesticular disorder of sexual development
Satit Klangsin P26. Agreement of two medical approaches with the expert consensus in identified the causes of primary amenorrhea in Songklanagarind Hospital
Cristina Laguna Benetti-Pinto P27. Sleep quality assessment in women with premature ovarian insufficiency using Hormonal Therapy
Li Li P28. Rare Copy Number Variants (CNVs) in the Genome of Chinese Female Adolescents with Turner Syndrome
Giovana Maffazioli P29. Evaluation of Differences in Clinical Characteristics Between Patients with the Classical Karyotype of Turner Syndrome and Mosaics
Sevara Nigmatova P30. Ovarian Function and Pregnancies in Women with Premature Ovarian Failure
Marjan Onabi P31. Rare and atypical cases of primary amenorrhea
Patrycja Rojewska- Madziała P32. Clinical, biochemical and genetic characterization of a 44- years old patient with primary amenorrhoea- case study of complete androgen insensitivity syndrome
Gyuzyal Tabeeva P33. The role of the expression of steroid receptors in ovaries of women with premature ovarian inssuficiency (POI).
Sharareh Abdollah P34. Missed Important Facts in diagnosis and treatment of Polycystic Ovarian Syndrome (PCOs)
Yulia Absatarova P35. Melatonin as a new pathogenetic factor in the development of anovulation in polycystic ovary syndrome
Yulia Absatarova P36. Pathogenetic effects of folate-containing combined oral contraceptive in patients with PCOS
CHANTAL AMISI P37. Wrist circumference: a new marker for assessing insulin resistance in sub-saharan african women with polycystic ovary syndrome
Mohamed Basly P38. vascular endothelial growth factor antagonist reduces the early onset and the severity of ovarian hyperstimulation syndrome Links
Adriana Carbonel P39. Effects of soybean isoflavones in rats model with polycystic ovary syndrome (pcos)
Adriana Carbonel P40. Action of melatonin, metformin, clomiphenic citrate in the ovary of rats in permanent estro
Sebastião de Medeiros P41. The interrelationship between anthropometric biologic markers of body fat distribution and steroid hormone biosynthesis in polycystic ovary syndrome
SHALINI GAINDER P42. Endometrial hyperplasia in infertile pcos women
Aleksandra Głowińska P43. Sexual Satisfaction in Women with Polycystic Ovary Syndrome
Roya Hosseini P44. Obesity and Insulin resistance in infertile women with polycystic ovary syndrome
Sujata Kar P45. 2D & 3D Trans-vaginal sonography to determine cut offs for ovarian volume and follicle number per ovary for the diagnosis of Polycystic ovary syndrome in Indian women.
Jasneet Kaur P46. Clinical application of the automated AMH assay for diagnosing PCOS in Indian women
Zurqa Khalid P47. TITLE: Circulating biomarkers for the diagnosis of Polycystic Ovarian Syndrome patients: A Meta-analysis
Daniela Koleva P48. Serum Visfatin Levels in Women with Polycystic Ovary Syndrome
Vilma Kovač P49. Policystic ovarian syndrome (PCOS) patients with higher body mass index (BMI) have significantly lower level of antimullerian hormone (AMH) and lower response on IVF/ICSI treatment
Yanglu Li P50. Comparing the risk of adverse pregnancy outcomes of Chinese polycystic ovary syndrome patients with and without anti-androgenic pretreatment
Ying li P51. Potential role of MicroRNA-32 on the proliferation of granulosa cells in polycystic ovarian syndrome women
Julia Nikolova P52. Serum levels of soluble E-selectin in polycystic ovary syndrome
Presiyana Nyagolova P53. Leptin And Galanin-like Peptide (GALP) Levels in Women With Polycystic Ovary Syndrome (PCOS)
Emma Öberg P54. Personality factors predicting successful weight loss in polycystic ovary syndrome
Maria Orbetzova P55. Serum levels of TNF-α and IL-6 in women with polycystic ovary syndrome
Christina Pagkaki P56. Polycystic ovary syndrome as a risk factor for premature ovarian insuffisiency: controversial data
Anastasios Potiris P57. Fibrinolytic defects, but not thrombophilic disorders, may be associated with recurrent miscarriages in women with polycystic ovary syndrome
Alessia Prati P58. Modulatory effects of D-Chiro-inositol (DCI) plus alpha lipoic acid (ALA) combination on metabolic and hormonal parameters of obese PCOS patients
Manuela RUSSU P59. PCOS and obesity as a cause for endometrial carcinoma in very young women – case presentation
Ricardo Simoes P60. Analysis of hyaluronic acid in the endometrium of women with polycystic ovary syndrome
Ricardo Simões P61. Action of melatonin, metformin, clomiphene citrate in the endometrium of rats in permanent estro
Katarzyna Suchta P62. Binge eating disorder in women with polycystic ovary syndrome.
Iroda Tojieva P63. Interrelation of paracrine factors and factors of proinflammation in patients with PCOS
Maria Helena Tur-Torres P64. Update of insulin resistance in adolescents with polycystic ovary syndrome and its relationship with hyperandrogenism and obesity in Vall Hebron Hospital population
DULARI VORA P65. Study to co-relate incidence of ovarian cysts / tumors in patients with bulky ovaries or polycystic ovarian disease (PCOD) and/or obesity
Husheng Wang P66. Clinical predictive value of anti-Müllerian hormone in polycystic ovary syndrome
Rafał Watrowski P67. Spontaneous life-threatening ovarian hyperstimulation in a patient with severe diabetes and unrecognized polycystic ovarian syndrome
Giulia Despini P68. Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients
Ivika Jakson P69. Insulin and the Down-regulation of Glucose Transporter 1 in Decidualizing Endometrial Stromal Cells
Felipe Serrano P70. Insulin sensitivity and testicular function in a cohort of adult males suspected of being insulin-resistant
Milina Tancic-Gajic P71. Insulin resistance in severely obese women after weight loss
HACER ALAN DIKMEN P72. The Relationship Between Maternal Obesity and Prenatal Attachment
Eleni Armeni P73. Adiposity measures and bone mineral density are associated with ovarian volume after the menopausal transition
Aleksandra Atanasova Boshku P74. Serum Sex Hormone Binding Globulin (SHBG) Relation with Different Components of Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Livia Dainelli P75. The Short-Term Economic Burden of Gestational Diabetes Mellitus in Italy
Mónica Flores-Ramos P76. Is waist-circumference related to anxiety levels in peri and postmenopausal women?
Rail Gazizov P77. Identification of metabolic syndrome and overweight among university teachers
Roya Hosseini P78. Diagnostic value of pre-gravid body mass index in determining of gestational diabetes mellitus in assisted reproduction technology
Sana Menjli P79. Obesity:physiologic changes and challenges during laparoscopy
Eliana Nahas P80. Isolated vitamin D supplementation improves the metabolic syndrome risk profile in postmenopausal women: a randomized, double-blind, placebo-controlled trial
Nur Nahdiyat P81. The impact of obesity to increase the risk of miscarriage in reproductive women
Laura Seco P82. Parental nutrition: methyl donors and nutri-epigenomics.
Marianna Torok P83. Gender differences in the biomechanics and vasoreactivity of coronary resistance arteries in exercise induced left ventricular hypertrophy
Hasmik Bareghamyan P84. Pregnancy and spontaneous preterm rupture of membranes
Hasmik Bareghamyan P85. A clinical case report: PREGNANCY, TETRALOGY OF FALLOT OF THE FETUS AND PREMATURE RUPTURE OF THE MEMBRANES
MARIANA GARCIA P86. An extremely rare complication of type 1 diabetes mellitus: Pierre Mauriac syndrome.
Charalampos Siristatidis P87. Age at menarche in the prediction of clinical pregnancy and live birth outcomes following Assisted Reproduction Technologies
Iryna Tuchkina P88. Optimization of surgical management of adnexal torsion in girls
Ksenia Fris P89. Morphofunctional endometrium changes in women with autoimmune thyroid pathology and pregnancy losses.
Roya Hosseini P90. Premature Ovarian insufficiency and thyroid Autoimmunity
Elena Andreeva P91. Vitamins and microelements at the stage of pre-gravity preparation and during pregnancy in patients with endocrinopathies.
Cristina Benetti-Pinto P92. Android fat distribution directly affects thrombin-activatable fibrinolysis inhibitor (TAFI) levels in women with polycystic ovary syndrome
Ksenia Fris P93. The expression of paracrine factors in women with autoimmune thyroid diseases and reproductive failures.
Alejandro Hernandez P94. 25-hydroxyvitamin-D levels in women attending a private outpatient clinic in Medellín – Colombia, 2013-2014
Yumie Ikeda P95. Developing A Smartphone Application for Daily Records of Premenstrual Symptoms: How is it accepted by non-PMS patients?
Olga Leshchenko P96. The state of the system of neuroendocrine regulation in women with reproductive disorders and genital tuberculosis
Zarkhanim Mammadova P97. Outcomes of gynecologic and endocrinologic disorders among 0-20 years girls in Baku ( Azeraijan)
Siripen Ongsupharn P98. The effect of oligomenorrhea and factors affecting metabolic syndrome in Thai postmenopausal women
Vesna Salamun P99. GLP-1 Receptor Agonist Liraglutide increased IVF Pregnancy Rates in Obese Women with PCOS and previous poor response to first line reproductive treatments:: a Pilot Randomized Study
Polyxeni-Maria Sarli P100. Granulosa cell ovarian tumor and resistance to clomiphene citrate. A case report and review of the literature.
Egle Vaiciuliene P101. Quality of Life in Adult Women with Turner Syndrome
Jianhong Zhou P102. Change in health-related quality of life in the menopausal transition and its associated factors in Chinese middle-aged women
KATARZYNA BŁASZCZAK-ŚWIĄTKIEWICZ P103. Selectivity and biological functionality of new selective modulator of progesterone receptor – novel mesoprogestin and its effect on endometrium proliferation.
Alina Busan P104. Non-Contraceptive Benefits of Contraceptives – Retrospective Study in Clinical Hospital of Obstetrics and Gynecology “Prof Dr Panait Sarbu” Bucharest
Tatiana Tatarchuk P105. Non-contraceptive benefits of hormonal contraception for Ukrainian military women.
Natalia Aganezova P106. Emergency contraception among doctors and people without medical education
Klaus Nickisch P107. Contributions to Ulipristals mechanism of action as Emergency Contraceptive Agent
JASMINE LALL P108. Comparative study of postplacental cu-t insertion in vaginal and caesarean deliveries
Alina Mihaela Busan P109. Determinant Factors in Choosing the Contraceptive Method Based on the Age of Patient
Karine Tokhunts P110. Consistent and combined application of dienogest and LNG-IUS to decrease the risk of IUS expulsion
MUHAMMAD AZRAI ABU P111. Knowledge, Attitude and Practice towards Intrauterine Contraception Device among Doctors in an Urban City of Malaysia
Jean-Michel Foidart P112. Physical tests of the Levosert T-frame and its inserter provide objective parameters that confirm their safety and easiness at insertion
Nilson Melo P113. Prevention of unplanned pregnancy through subdermal implant in women users of illicit drugs in the region of cracolandia, São Paulo.
Iuliia Naumova P114. Adverse events of Essure® contraception. Analysis in a large cohort of patients.
Maria Antonia Obiol P115. Local complications associated with the insertion and removal of Implanon NXT®.
nelli nahapetyan P116. Consistent and combined application of dienogest and LNG-IUS to decrease the risk of IUS expulsion
Mohd Faizal Ahmad P117. Endometrial thickness and embryo quality in predicting the outcome of icsi and embryo transfer: a retrospective cohort study
Shi Yee Chen P118. Does trophectoderm morphology better in predicting euploidy compared to inner cell mass? A retrospective study
Ileana Alejandra G. Cantón P119. Effect of Claudin-1 expression on the sperm membrane on the blastocyst rate in euploid embryos
IOANNIS GIAKOUMAKIS P120. Importance of serum vitamin d in surrogacy motherhood program and ivf success rates
Laura Seco P121. Obesity and embryo development
ROBABEH TAHERIPANAH P122. Comparison of Serum and Uterine Flushing Concentrations of Glycodelin on Days 21-23 of Reproductive Cycle among Women with In Vitro Fertilization Failure versus Normal Fertile Women
Taisiia Yurchuk P123. Blastomere biopsy of incomplete compacted human morula can improve the embryo cryopreservation outcome
Abbas Majdi Seghinsara P124. The role of Ovarian Surface Epithelial Stem Cells (OSESC) in neo-oogenesis and cell therapy
EVANGELIA ZAPANTI P125. Interleukin 15 concentrations in follicular fluid and their effect on oocyte maturation in subfertile women undergoing intracytoplasmic sperm injection.
Mounir AJINA P126. Comparison of ICSI results in a group of patients with and without oral L-carnitine, acetyl-L-carnitine and nutrients supplementation
Agnieszka Dubiel P127. The prevalence of antinuclear antibodies (ANA) in AITD women with history of miscarriage
Francisco Sandoval Garcia Travesi P128. The expression of the Claudin family in the testis – a dynamic membrane behavior for sperm formation in patients with infertility
MUHAMMAD AZRAI ABU P129. Factors influencing poor prognosis for azoospermic men before intracytoplasmic sperm injection.
Karina Cázarez Pérez P130. Dna fragmentation, a nuclear evaluation for sperm production during life years.
Ali Gurbuz P131. Medical treatment of İsthmocele with Gonadotropin Releasing Hormone Agonists (GnRHa) before frozen thawed embryo transfer- A preliminary report
Fatemehsadat Hoseini P132. A non-randomized controlled trial of oral melatonin supplementation on ATPase 6 gene expression and IVF outcomes in Iranian infertile couples
Jehona Luta P133. Pregnancy after hysterosalpingography
Zoia Rossokha P134. The shift in emphasis of infertility genetic risk caused by defects in folate related gene polymorphism
Charalampos Siristatidis P135. Age of subfertile women and clinical pregnancy outcome following Assisted Reproduction Technologies
Deniss Sõritsa P136. Physical activity of infertile women before, during and after in vitro fertilization treatment and its effect on pregnancy outcome
Julio Avilés P137. Effect of Tadalafil on endometrial thickness, receptivity in assisted reproduction cycles and its reproductive results
Andreea Carp-Veliscu P138. Autologous platelet-rich plasma in endometrial growth: our clinical experience
Gabriella Donà P139. Effect of astaxanthin on human sperm capacitation: in vivo and in vitro studies
Mariia Mazilina P140. Morula-stage embryo vitrification in cryopreservation cycles: five years of positive experience
Diana Mihai P141. Has the ‘freeze-all” strategy a better pregnancy outcome?
Marco Noventa 142. Ultrasound- Guided Embryo Transfer: Summary of Evidences to Close the Open Debate and Unlock New Perspectives. Literature Review and Meta-Analysis
Ales Sobek P143. Treatment of low oocyte quality in the Czech Republic
Vanessa Trindade P144. The use of intravenous lipids emulsion in reproductive medicine: An Experience at Fertilitat – Center of Reproductive Medicine
Asiyat Rabadanova P145. Three Dimensional Power Doppler and the efficiency of IVF cycles.
Ali Gurbuz P146. Evaluation of dual trigger with combination of gonadotropin releasing hormone agonist and human chorionic gonadotropin in improving oocyte-follicle ratio in normo-responder patients
Krzysztof Lukaszuk P147. Novel multiple consecutive stimulation protocol – shortening duration of infertility treatment
Manuela Neagu P148. Monoovulation Induction with Aromatase Inhibitors – Retrospective Clinical Study
Svetlana Spremovic-Radjenovic P149. Letrozole versus clomiphene as the first-line treatment for anovulatory infertility in women with pcos
Siti Nabillah Ab Rahman P150. Right or Left Ovary: Which has better ovarian response? A study of ART outcome in IVF patients in HSNZ Kuala Terengganu, Malaysia.
Marta Sestero P151. Ovarian sensitivity index and Follicular Output Rate are good measure of ovarian responsiveness to gonadotrophin stimulation
Nasuha Yaacob P152. The Influence of serum estradiol levels on the day of ovulation trigger on assisted reproductive outcome in HSNZ Kuala Terengganu, Malaysia.
Yolanda Cabello P153. Establishment of a protocol for severe endometriosis management and ovarian stimulation for IVF treatment. First pregnancies and newborn children.
Maria Luisa Gasparri P154. Origin of placental disorders after assisted reproduction: Assisted reproduction itself or Endometriosis as its indication
SZE MAN LAW P155. In-vitro fertilization (IVF)/ Intracytoplasmic Insemination (ICSI) Outcomes in Endometriosis- Related Infertility: 8 years Results from an Assisted Reproductive Unit
ANA RODRIGUEZ BUJEZ P156. Endometriosis and tubo-ovarian pelvic abscess after oocyte retrieval
Yolanda Cabello P157. Proposal of necessary tests for all the patients before Assisted Reproduction Treatments in order to prevent factors that could affect implantation failure, miscarriages or other gestational complications.
yu liang P158. The effects of insulin-like growth factor-I on IVF outcome of diminished ovarian reserve
ANA RODRIGUEZ BUJEZ P159. Five years on fertility preservation public program
JOSÉ SOARES-JR P160. Melatonin antiproliferative effects in rats frozen-thawed ovarian autografts: preliminary findings in a scaffold-based delivery
José Soares-Jr P161. Melatonin effects on ovarian tissue cryopreserved transplantation
Xiadi Huang P162. Association of coenzyme Q10 with premature ovarian insufficiency
Chunming Li P163. Pyrethroid Pesticide Exposure and Risk of Primary Ovarian Insufficiency in Chinese Women
shiba abdollah P164. Evaluation of serumic progesterone`s level with pregnancy out come in frozen embryo transfer
ROSOLINO CATANIA P165. The association of Anti-thyroid Peroxidase Antibodies and anti-Phospholipid antibodies in recurrent miscarriage A literature rewiew.
Dmytro Konkov P166. The preventive strategy of cervical incompetency
ADRIANA RAMALHO P167. Interstitial Ectopic Pregnancy in High Risk Maternity in the Amazon Region: Case Report
Tejal Poddar P168. Double trouble: a rare case of bilateral ectopic pregnancy following intracytoplasmic sperm injection
Ana Azcárraga Sapena P169. Comparison of cesarean section rate and demographic risk factors between 2008-2016 at clinic university hospital of valencia
Mira Bittár P170. Reasons for planned, urgent and immediate cesarean sections and actions to prevent unnecessary cesareans
STEFANIA TRIUNFO P171. Health care cost analysis for deliveries according to the maternal age classes in an university hospital setting: a five-years retrospective cohort study
Hasmik Bareghamyan P172. Pregnancy and Tetralogy of Fallot
aziza chemima P173. Iniencéphalie: Diagnostic amtenatal d’une pathologie rare et revue de la littérature
Zaklina Jurisic P174. Advance 3D Ultrasound techniques in detection of cleft palate from 12-18th week of pregnancy
ADRIANA RIBEIRO RAMALHO P175. Malaria vivax in pregnant attended in a school hospital of amazon region
Andrea Sepulveda P176. Obstructed Hemivagina and Ipsilateral Renal Anomaly Syndrome (OHVIRA) in pregnancy: A CASE REPORT

19:05 Wednesday 7th

Poster Area Poster Session 19:05 ￫ 21:00
From 177 To 365 See the posters that will be presented!

Yauheniya Tsikhanovich P177. Doppler studies in patients with chronic venous disease and prediction of neonatal hypoxia.
Nurezwana Elias P178. A case report: Fatal outcome of cerebral venous sinus thrombosis with cerebral hemorrhage due to antithrombin III deficiency during early pregnancy
Hasmik Bareghamyan P179. Pregnancy, severe oligohydramnios and tetralogy of fallot of the fetus
emilio diaz P180. Exosomal miRNA profile in gestational diabetes – Potential role in placental metabolism
Ziwen Jiang P181. Translocation of placental target pullulan based nanoparticle drug delivery system in an in vitro placental
Hasmik Bareghamyan P182. Pregnancy and HLA incompatibility
Hasmik Bareghamyan P183. Pequliarity of pregnancy and labor in women with hla incompatibility
Gagik Beglaryan P184. Hla incompatibility and pregnancy
Anastasiya Novikova P185. Pregnancy and intrauterine infection in adolescents
ADRIANA RIBEIRO RAMALHO P186. Immune Thrombocytopenic Purpura in Pregnant Women in the Amazon Region: Case Report
Elena Costa P187. Change in prevalence of Gestational Diabetes and obstetric complications when applying IADPSG screening criteria in a Belgian French population
Elena Khazova P188. Two seasons of the level of calcidiol in pregnant women of St. Petersburg.
Tatyana Novikova P189. Obstetric-gynecological risk factors for osteopenia in the postpartum period
Manuela Cristina Russu P190. Pregnancy outcome in the dual endocrinopathy diabetes mellitus and hypothyroidism. 5 years retrospective study
Florije Spahija P191. 30 doses of platelets that saved a case of immune-thrombocytopenia
Irina E. Zazerskaya P192. Vitamin D deficiency and pregnancy outcomes.
Alejandra Elizalde Cremonte P193. Current state of gestational diabetes (dg) in our maternity. Corrientes. Argentina. 2017
Chung-Yi Li P194. A nationwide case-control study of gestational diabetes mellitus in association with air pollution in Taiwan
Manuela Stefana Neagu P195. Metformin improves the obstetrical outcome of women with gestational diabetes
Imre Tormasi P196. Association of pathological tyrosine isoforms with parameters of hematopoiesis in hyperfiltrating physiological pregnant women
Paweł Bartnik P197. Attendance to antenatal classes reduces perinatal pain and fear in primiparous women.
Patricija Kasilovska P198. Unexpected pregnancy-is it a big problem?
Jehona Luta P199. The importance of information for Rh-immunization
Nor azila Mohd Nafiah P200. Women with hyperemesis gravidarum: does acupressure wristband helps in reducing severity?
JOSE RANGEL PADILLA P201. Depressive syndrome secondary to spontaneous abortion and its correlation with the clinical history of the patients treated in the gynecology and obstetrics service at Dr. Dario Fernandez Fierro Hospital Mexico City
Magdalena Smyka P202. Obstructive sleep apnea is a risk factor of preterm delivery
Merita Vuniqi-Krasniqi P203. Adolescent pregnancy in Kosovo
Pinar Yalcin Bahat P204. Episiotomy approach to the women of postpartum persistent migrain cases
Andrea Sepulveda P205. Cervical cerclage of rescue in the management of cervical incompetence. Experience of luis tisne brousee hospital
Umida Ashurova P206. Associations of vascular tone genes polymorphisms in pregnancy-induced hypertension among Uzbek women: a case-control study.
Ofelia Bettikher P207. Association between fasting serum C-peptide level, obesity, preeclampsia and gestational diabetes
Karol Charkiewicz P208. Syndecan 4, galectin 2 and DR3 as a novel factors in pathways of mild preeclampsia – protein macroarray screening.
Karol Charkiewicz P209. Sphingolipids screening in plasma of women with preeclampsia.
EDNEA DE OLIVEIRA P210. HELLP Syndrome: Case Report
Sabine Enengl P211. The sFlt-1/PlGF ratio and its predictive value concerning time to delivery in patients with preeclampsia- Preliminary Data
Feriha fatima Khidri P212. VEGF gene polymorphisms and serum VEGF levels in preeclampsia
Galina Khlestova P213. Disturbancies of the balance of vasoconstrictors and vasodilatators in the maternal blood plasma in the genesis of preeclampsia
Dmytro Konkov P214. The modern hemodynamic features of predictive diagnosis of preeclampsia
Tetiana Loskutova P215. Metabolism and lipids peroxidation in women with preeclampsia
Natalia Pasman Natalia Pasman P216. Pasman N.M., Chumanova O.V., Voronina E.N., Philipenko M.L., Drobinskaya A.N. Assessment of a role of hemostasis system genes polymorphism and the genes which are responsible for formation of an endothelium dysfunction in development of gestational complications
Sahadete Shala P217. Hypertension induced by pregnancy after In Vitro Fertilization and Embryo Transfer
Charalampos Siristatidis P218. The role of interleukins in preeclampsia: a comprehensive review
sapiyat ibragimova P219. The role of gene polymorphisms of the renin-angiotensin in the etiology of early and late preeclampsia actuality
Danijel Bursac P220. Acute pulmonary oedema in pregnant women with the use of beta-agonists
Shqipe Fetiu -Salihu P221. Pregnancy after In Vitro Fertilization and cervical cerclage
Richard Mayer P222. Should all patients with congenital heart disease, WHO group III or higher, be advised against pregnancy?
YOSHINO SAITO P223. Whether do Japanese pregnancy women know the effect of sodium and potassium to blood pressure or not.
Andrea Sepulveda P224. Hemoperitoneum in ambdominal pregnancy: a case report
Manijeh Mehdinejad P225. Study of bacteriuria in pregnant women and determination of their antibiotic susceptibility patterns
Alexandra Ursache P226. Ultrasound parameters to evaluate HIV positive pregnant women
Georg Gruessenberger P227. Birth mode in twin-pregnancies- Outcome based on the Apgar-Score 5 minutes after delivery
Ija Lisovaja P228. Hyperreactio luteinalis in twin pregnancy, a case report.
Mohd Faizal Ahmad P229. Amniotomy and early oxytocin infusion versus amniotomy and delayed oxytocin infusion in nulliparous women: a randomised controlled trial
Anna Thorbiörnson P230. Oral versus vaginal prostaglandin for labor induction
Alexandra Ursache P231. The utility of ultrasound examination in the surveillance of misodel induced labor
Kistaman Dzhamalutdinova P232. Immunohistochemical characteristic of stem cells markers in foci of nodular and diffuse adenomyosis.
Faina Guseinova P233. Efficacy of transplantation of bone marrow stromal mesenchymal cells in the therapy of female genital tuberculosis in rabbits (experimental-morphological study)
Li Ling P234. Effects of human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation on chemotherapy-induced primary ovarian insufficiency in rats
Elena Usoltseva P235. Endometrial stem cells homing to injured and intact endometrium
Olena Gnatko P236. Ovarian reserve in adolescent girls born with intrauterine growth retardation
Nigar Kamilova P237. Assessment of risk impacts on the development of obesity in adolescent girls
Anastasiya Novikova P238. Gynecological disorders on the background of stress during puberty
Iryna Tuchkina P239. Urgent conditions in pediatric and adolescent gynecology
Chiara Cassani P240. Sexual function and distress in natural menopausal women and breast cancer survivors with signs and symptoms of vulvo-vaginal atrophy/genito-urinary syndrome (vva/gsm).
Juan Du P241. Effects of Oral Contraceptives on Sexual Function in PCOS Patients
Lara Tiranini P242. Exploring the relationship among sexual function, cues for sexual desire and psychological general well-being in a sample of healthy women seeking hormonal contraception.
aziza chemima P243. Hormonal disorders among Adolescents
Miho Egawa P244. Development of a smartphone application system for symptom-recording to manage premenstrual syndrome and its clinical use
Kazuko HIYOSHI P245. Brain Bold Signal-Based Blood Flow Tracking by fMRI with menstrual cycle on healthy women.
Hisayo Okayama P246. The relevance of Sense of Coherence to Premenstrual Dysphoric Disorder and depression state of young women in Japan
Jelena Otasevic P247. Lower levels of serum vitamin D are in correlation with reduced ovarian reserve
Vira Pyrohova P248. Combined hyperproliferative processes of the reproductive organs and vitamin d deficiency
Patimat Khirieva P249. The condition of the endometrium in women of reproductive age with intrauterine adhesions.
Yinmei Dai P250. Diagnostic and therapy effect of hysyeroscopic technology in abnormal uterine bleeding
YU SUN P251. FIGO classification system (PALM-COEIN) for causes of chronic abnormal uterine bleeding in Chinese women of reproductive age
Tze Tein Yong P252. Heavy menstrual bleeding, iron deficiency and its impact in exercising females in Singapore
cristina benetti-pintp P253. Quality of life in women with deep endometriosis
Tatiana Efimenko P254. Features of innervation of ectopic endometrium in women with chronic pelvic pain
Patricija Kasilovska P255. Pelvic pain: relation between endometriosis and other factors
Olga Leshchenko P256. The frequency of clinical symptoms in a combination of genital tuberculosis and external genital endometriosis in women with infertility
Ma. Paula Rhove Ortega P257. Abdominopelvic Tuberculosis Presenting as Vaginal Synechiae with Hematopyotrachelometra
Linda Vignozzi P258. Outcome of medical and psychosexual interventions for Vaginismus: a systematic review and meta-analysis
Vladimir Zuev P259. The value of express laser spectroscopy in the diagnosis of the uterine abnormalities in perimenopausal women
DooSeok Choi P260. Spontaneous pregnancy in patients who received three cycles of gonadotropin-releasing hormone agonist treatment after conservative laparoscopic ovarian endometrioma surgery
Fabio Barra P261. Estimation of bowel stenosis degree in women with colorectal endometriosis: a prospective comparative study
Gamze Sinem Çağlar P262. Matrix metalloproteinase-9 and neutrophil gelatinase-associated lipocalin levels in advanced stage endometriosis
Diana-Elena Comandasu P263. Immunohistochemistry evaluation of endometriosis implants in patients following preoperative progestative treatment
Svetlana Dubrovina P264. Prognosis of recurrence of endometrioma after surgery
Tatiana Kleimenova P265. Identification of kisspeptins and matrix metalloproteinases in endometrial cell culture from patients with endometriosis
Tamara Knific P266. Novel diagnostic models for endometriosis including serum CA-125 levels, body mass index, cyst pathology, dysmenorrhea or dyspareunia
Juanqing Li P267. The roles of cell migration and invasion mediated by Twist in endometriosis
Ekaterina Pshenichnyuk P268. Immunohistochemical predictive factors for recurrence of ovarian endometrioma after laparoscopic excision
Ekaterina Pshenichnyuk P269. Identification of global transcriptome abnormalities in eutopic endometria of women with endometriosis: potential biomarkers of endometriosis
Magdalena Rogut P270. Is it possible to diagnose endometriosis at the level of endometrium?
cristina benetti-pinto P271. How deep is your love”: evaluation of dyspareunia and sexual function in women with deep infiltrating endometriosis in long-term treatment with dienogest
Oleksandra Gromova P272. Low-dose progestins reduse endometriosis associated pain
Nigar Kamilova P273. Differentiated approach to the diagnosis and prevention of genital prolapse in women
Alexandra Mihaila P274. Can osteopontin be considered a biomarker for endometriosis?
Zorana Stojanovic P275. Potential immunoprotective role of dheas on endometriosis in premature ovarian insufficiency patients
Maria Yarmolinskaya P276. Investigation of the effects of metformin in a rat endometriosis model.
Dzmitry Buryak P277. Pharmacological therapy of uterine fibroids: prediction and durability of treatment effect
Maria Yarmolinskaya P278. Changes of molecular characteristics of endometrium in patients with leiomyoma treated with selective progesterone receptor modulators (SPRM)
Klaus Nickisch P279. EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human fibroid tissue xenograft model
Ekaterina Borovkova P280. The effect of local preparations containing glucocorticoids on indicators of local immunity and the activity of the human papillomavirus Borovkova E. I.
Miguel Bedoya Osorio P281. Effect of the administration of 50 mg orally of dehidroepiandrosterone (dhea) during 12 months in: sexual function, somatometry, bone mineral density and metabolic variables of the posmenopausic women of the menopause clinic at the hospital juarez de mexico: preliminary results at 6 months
Aleksandar Djogo P282. Influence of the level of dehydroepiandrosterone sulphate (dheas) on the body weight of the climacteric women
Joanna Bartosiewicz P283. An analysis of the relationship between the polymorphism of certain genes in candidates for cognitive impairments against cognitive functions in female white-collar workers
Gabriella Gyovai P284. Perimenopausal attention deficit as diagnostic challenge
Blazej Meczekalski P285. Climacteric symptoms severity and thyroid hormones status in menopausal women.
Raquel Picó P286. Using ICT to improve adherence to physical activity with and educational program with postmenopausal women.
Eleni Armeni P287. Subclinical atherosclerosis and calcium metabolism in apparently healthy, non-diabetic postmenopausal women.
Eleni Armeni P288. Women with the metabolic syndrome have evidence of subclinical arterial disease early after menopause
Peter Chedraui P289. Pharmacokinetics of two monthly formulations of non-polymeric microspheres of 17β-estradiol and progesterone administered intramuscularly in an aqueous suspension in postmenopausal women
Milton Daniel Flores Fuentes P290. Incidence of insulin resistance in postmenopausal women at Human Reproduction’s Biology clinic during the period 2016 – 2017 at Hospital Juárez de México
Evaggelia Karopoulou P291. Subclinical atherosclerosis and lactation history in women after menopause.
Yana Kostroma P292. Individual approach to reduction of the risk of somatic pathology in postmenopausal women using hrt
Andrea Martínez Massa P293. Cardiovascular risk factors in postmenopausal women from two spanish regions (camargo and carmen cohorts)
Denny Salazar-Pousada P294. Weight gain and metabolic changes during the menopausal transition in Ecuadorian women.
Guiju Cai P295. Research on Correlation between the Blood Concentration of Progesterone Receptor Membrane Component-1 and the Molecular Subtypes of Breast Cancer Patients
Maria Helena Presado P296. Sexuality and Breast Cancer
Ying Zhang P297. Can increased expression of progesterone receptor membrane component 1 also indicate a worse prognosis in triple negative breast cancers?
Yue Zhao P298. Overexpression of Progesterone Receptor Membrane Component-1 is Associated with Malignant Phenotypes of Breast Cancer
Susanna Gasparyan P299. The role of combined hormonal therapy in the correction of cognitive disturbances in women in menopause
Nilson Melo P300. Evaluation of risk factors for osteoporosis in post-menopaused women with background of endometriosis and submitted to hormonal treatment.
Eliana Nahas P301. Effect of isolated vitamin D supplementation on the bone turnover markers in younger postmenopausal women: randomized, double-blind, placebo controlled trial.
Antonina Smetnik P302. Screening for osteoporosis in amenorrheic and postmenopausal women
Stefania Alvisi P303. Changes of vulvar and vaginal tissue morphology following ospemifene intake in postmenopausal women with vulvovaginal atrophy (vva)
Adriana Carbonel P304. Actions of phytoestrogens or estrogens on the proliferation of the rat in uterine cervix
Adriana Carbonel P305. Soybean isoflavone decreases oxidative stress in the uterus and vagina of ovariectomized rats
Rodolphe Perard P306. Treating patients with vulvar and vaginal atrophy and a history of breast cancer could substantially reduce the Italian NHS resource use
Mekan Orazov P307. Antioxidant – regenerative therapy – a new anti-aging concept of women in peri and postmenopausal age
Johann Röhrl P308. Cimicifuga racemosa dry extract (BNO 1055) as active component of Klimadynon® improves sleep quality through GABAA-ergic activity
Sofia Thorell P309. Effects of Resistance Training in Postmenopausal Women on Muscle Strength and Total as well as Fat-free Muscle Mass measured with MRI
A. Glazunova P310. Low-dose local hormonal therapy for VVA in postmenopausal women.
Dubravko Lepusic P311. Education adolescents about sexuall responsible behavior and preventing HPV infections-Health education in Croatia
Ziad Abouzeid P312. Expression of vascular endothelial growth factor receptors in endometrial carcinoma
Yinmei Dai P313. Identification of DNA hypermethylation of SOX9 in association with cervical cancer using CpG microarrays
Kelly Ferreira P314. Non-canonical activation of SHH signaling as a metastatic marker in vulvar cancer
Kelly Ferreira P315. Tetraspanins CD63 and CD82 as markers of prognosis in vulvar carcinoma cells
Suzana Vidic P316. The importance of estrone-sulfate transporters in endometrial cancer
Chenghong Yin P317. Quantitative methylation detection of SOX9 in cervical cancer scrapings using TaqMan probes
Anna Drobintseva P318. New approach to detection and analysis of cancer-associated proteins in fluorescent digital microscopy
Ziad Abouzeid P319. Potential role of platelets and lymphocytes in epithelial ovarian cancer
Natalia Artymuk P320. The predictive value of the self-sampling of human papillomavirus DNA for the diagnosis of HSIL and cervical cancer in different social group
Man-Kin Chung P321. The application of community based self-sampling for STD and HPV screenings in Chinese population
Maddalena Mallozzi P322. Anamnestic-ultrasound features and endometrial cancer risk in tamoxifen user patients: useful insights in a controversial topic.
Nur Nahdiyat P323. Community diagnosis of visual inspection with acetic acid in primary health center of klender district, indonesia
Gulaim Ataniyazova P324. Human papilloma virus and cervical pre-cancer
Valeria Barra P325. Prevalence of HPV genotipes in the senese female population undergoing cervical screening
Russell Ng P326. Neglected HPV infection status in men: A possible underlying cause for persistent high cervical cancer rate among women?
Touhami Omar P327. Primary Non-Hodgkin’s Lymphoma of the Ovary – A Case Report
ALVARO MONTERROSA-CASTRO P328. Description of the quality of life in colombian women caribbean survivors of breast cancer
Omar Touhami P329. A diagnostic dilemma for solid ovarian masses: the clinical and radiological aspects with differential diagnosis of 5 cases
Cialuj Teza Agbayani P330. Ovarian masses in children and the trend towards ovarian conservation: a case report
Diana-Elena Comandasu P331. Pregnancy outcome after radical vaginal trachelectomy with laparoscopic pelvic lymphadenectomy performed as a fertility preservation technique in patients with early-stage cervical cancer
Kristel Danica Panes P332. A Case Of Primary Fallopian Tube Carcinoma Who Underwent Hyperthermic Intraperitoneal Chemotherapy In A Third World Country
Ekaterina Borovkova P333. Breast cancer associated with pregnancy. Dobrokhotova J., Danielian S., Borovkova E. аnd Zalesskaya S. A.
Lino Del Pup P334. Breast cancer risk of hormonal contraception and hormone replacement therapy: how to counsel and reassure patients considering recent evidence.
Maximilian Brincat P335. A Case Of Primary Ovarian Insufficiency In A 21 Year Old Woman With A Strong Family History Of Breast Cancer
Alfred Mueck P336. Membrane-initiated effects of Serelys® on proliferation and apoptosis of human breast cancer cells
Fulvio Borella P337. Clinicopathological features of pure mucinous breast carcinoma: our experience of 35 cases
Muqing Gu P338. Does Norethisterone stimulate human breast cancer cells proliferation by promoting PGRMC1 expression?
Aysel Zeynalova P339. Possible benefits of metformin use in patients with breast cancer
Nelly Sogoyan P340. Somatic mutations in gene MED 12 among women with the family history of uterine fibroids.
Natalia Artymuk P341. The prevalence of the pelvic floor dysfunction of in reproductive age women
Balazs Erdodi P342. The Value of Perineal Ultrasound Scan in the Diagnosis of Peri- and Postmenopausal Urinary Incontinence
Kiyoko Naito P343. Evaluation of the effectiveness of the motion picture using magnetic resonance images for the pelvic floor muscle training
Sanae Ninomiya P344. Effectiveness of the moderately supportive underwear in women with stress urinary incontinence, Part 2: Are the symptoms of urinary incontinence reduced due to wearing the underwear? An assessor-blinded randomized control trial
Sanae Ninomiya P345. Effectiveness of the moderately supportive underwear in women with stress urinary incontinence, Part 1: Is the bladder neck elevated due to wearing the underwear?
Elisa Malacarne P346. Efficacy and safety of robotic-assisted apical lateral suspension for the treatment of high grade pelvic organ prolapse: short and medium follow up
Manuela RUSSU P347. The use of deepithelialized vaginal flap, associated with synthetic mesh fixation at sacrospinous ligaments, for grade 3-4 genital prolapse surgical treatment
Manuela RUSSU P348. Sacrosuspension vs fixation at sacrospinous ligaments in pelvic organ prolapse treatment
Tommaso Simoncini P349. Single site robotic-assisted apical lateral suspension (ss r-als) for advanced pelvic organ prolapse: first cases reported
Rafał Watrowski P350. Laparoscopic, pregnancy-preserving management of massive hemoperitoneum after corpus luteum cyst rupture in early gestation
Elena Cecchi P351. Early experience using new integrated table motion for the da Vinci Xi in gynecological surgery: feasibility, safety, efficacy.
ahmed galal P352. Accuracy of three –dimensional- ultrasound and Magnetic resonance imaging in the diagnosis of mullerian duct-anomalies
SZE MAN LAW P353. Precise Imaging of Endometrium using real time rotational pullback Optical Coherence Tomography: A pilot study
Nur Nahdiyat P354. Detection of lactate and other metabolites in ovarian tumours using 1H NMR Spectroscopy
Victor Suturin P355. Uterine tissue microcirculation assessment by sidestream darkfiled (SDF) imaging as a complimentary method to ultrasonography: a pilot study.
Laura Batres Martínez P356. Ambulatory hysteroscopy: Statistics of our center
Laura Batres Martínez P357. Failed ambulatory hysteroscopy: evaluation of patients, causes and treatments
Simone Bruni P358. Outpatient Hysteroscopy: factors affecting pain perception
Edson Ferreira Filho P359. Hysteroscopic intratubal device Essure® for permanent contraception: clinical outcomes and complications
Patimat Khirieva P360. Differential gene expression in the endometrium of reproductive age women with intrauterine adhesions.
Elena Nada P361. Hysteroscopy as an Essential Diagnostic Tool in Infertile Women
Giulia Nencini P362. Does obesity influence office hysteroscopy? An observational study.
Anna Rosner-Tenerowicz P363. Histeroscopic treatment of AUB due to Robert’s Uterus
Simona Scarani P364. Correlation between hysteroscopic and anatomopathological finding in endometrial pathology
Tanvir Tanvir P365. mbulatory Hysteroscopy for Retained Products of Conception following first trimester medical abortion

Thursday 8th March 2018

08:30 Thursday 8th

Auditorium Meet the Experts 08:30 ￫ 09:30
SPRM

Chairperson/s: Jean Francois Arnal

Philipe Bouchard Selective progesterone receptor modulators (SPRMs): update on the clinical results in fibroids
Kristina Gemzell Danielsson SPRMs for contraception with added health benefits

Affari 1 Meet the Experts 08:30 ￫ 09:30
Bilateral oophorectomy in pre-menopausal women

Chairperson/s: Martin Birkhaeuser

Walter Rocca It is time to stop unjustified oophorectomies
John Studd It is time we learn to treat oophorectomized women correctly

Affari 0 Corso Superiore di Ginecologia Endocrinologica AIGE 08:30 ￫ 11:30
PCOS e dismetabolismo

Chairperson/s: Alessandro Genazzani

Vincenzina Bruni Fattori genetici ed epigenetici predisponenti la PCOS
Li Xiao Anthropometric index to predict insulin resistance in women with polycystic ovary syndrome in China
Antonio Cianci L’ insulino resistenza della PCOS e le strategie terapeutiche
Antonio Lanzone Il trattamento degli iperandrogenismi
Gianluca Gennarelli PCOS e rischio oncologico

Affari 2 Scientific Society Symposium 08:30 ￫ 09:30
Contraception: interesting aspects – Organized by the European Society of Contraception and Reproductive Health (ESC)

Chairperson/s: Gabriele Merki , George Bartfai

Regine Sitruk-Ware Potential neurological benefits of progesterone and progestins used in contraception
Gabriele Merki Course and treatment of headaches and migraine in the pillfree interval
George Bartfai Contraception in women with seizure disorder

Verde Scientific Society Symposium 08:30 ￫ 09:30
Update in Ovarian Cancer- Organized by the Société Européenne de Langue Franco-Allemande de Gynécologie-Obstétrique (SELFAGO)

Chairperson/s: Adolf E. Schindler , René Druckmann

Laura Knabben Genetic testing in ovarian cancer
Christian Singer Prevention strategies in women with hereditary breast and ovarian cancer syndromes
Walther Kuhn Impact of lymph node dissection in ovarien cancer
Emmanuel Barranger Advanced ovarien cancer: preoperative prediction of resectibility

Affari 4 Scientific Society Symposium 08:30 ￫ 09:30
The Brazilian experience in Polycystic Ovary Syndrome – Organized by the Sociedade Brasileira de Ginecologia Endocrina (SOBRAGE)

Chairperson/s: Edmund Baracat

José Soares-Jr Leraglutide and bariatric surgery. Definituve treatment of PCOS patients
Nilson R. De Melo Benefits and harms of combined oral contraceptive in PCOS
Sebastiao de Medeiros Clinical and biochemical features of Brazilian PCOS patients

Onice Scientific Society Symposium 08:30 ￫ 09:30
Panel Discussion “From Conception to delivery in Indian PCOS” – Organized by the PCOS Society of India

Chairperson/s: Sujata Kar

Sujata Kar .
Nalini Mahajan .
Anita Soni .
Ritu Joshi .
Madhuri Patil .

Sala 4 Scientific Society Symposium 08:30 ￫ 09:30
Session organized by the German Society of Gynecological Endocrinology and Reproduction (DGGEF)

Chairperson/s: Ludwig Kiesel , Liselotte Mettler

Petra Stute Measuring active and healthy ageing
Martin Goette MicroRNAs – ready for endometriosis diagnostics ?
Annette Bachmann PCOS – a lifelong disorder ?
Amanda Machado Weber Metformin and endometrial function

09:45 Thursday 8th

Auditorium Symposium 09:45 ￫ 11:15
Premature labor: how to prevent, how to manage

Chairperson/s: Peter Chedraui , Takeshi Maruo

Tomoyuki Fujii Omega-3 polyunsaturated fatty acid and preterm birth
Fabio Facchinetti Maintenance tocolysis. Still unsolved problem
Gian Carlo Di Renzo Prediction and prevention of preterm birth
Christian Egarter Progesterone: mode of action in preterm labor

Affari 1 Scientific Society Symposium 09:45 ￫ 11:15
Alliance of the surgeon and gynecologist-endocrinologist in reproductive medicine – Organized by the Russian Association of Endometriosis

Chairperson/s: Leila Adamyan , Vladimir N. Serov

Leila Adamyan Endometriosis – an integrated approach of the treatment
Maria Yarmolinskaya Infertility in patients with gynecological diseases – the role of hormone therapy in the preparation for IVF and in the luteal phase support
Irena Kozachenko Optimization of infertility treatment results in gynecological patients. Role of the surgeon in the preparation for IVF. “Pros and cons”
Nana Tetruashvili Recurrent pregnancy loss
Martynov Sergei and Arakelyan Alek Postoperative synechiae, inconsistent uterine scar and niches. Methods of diagnosis, surgical and medical treatment

Affari 2 Symposium 09:45 ￫ 11:15
ART – New therapies and new challenges: the individual factors

Chairperson/s: Paolo Artini , Zion Ben Rafael

Jacques Cohen Assisted reproductive technology treatments, limitations and prospects for mitochondrial disease carriers
Basil Tarlatzis The use of androgens or androgen – modulating agents in poor responders undergoing in vitro fertilization
Alberto Revelli Multivariate prediction model for IVF results: a tool to get benchmark

Verde Scientific Society Symposium 09:45 ￫ 11:15
Menopause medicine: think sexuality! – Organized by the International Menopause Society (IMS)

Chairperson/s: Mary Ann Lumsden , Sunila Khandelwal

Susan Davis Sexuality and the postmenopausal woman
Rossella E. Nappi Treating sexual symptoms at midlife
Michael van Trotsenburg Sexuality of Transgender Persons
Susan Davis New process of care for HSDD

Affari 4 Scientific Society Symposium 09:45 ￫ 11:15
Gynecological Endocrinology and the Women Health’s future – Organized by the Asociacion Latinoamericana de Endocrinología Ginecologica (ALEG)

Chairperson/s: Alejandro Paradas Caba , Alejandro Manzur

German Salazar Trends in contraceptives use among adolescents
Imelda Hernandez Long term polycystic ovarian syndrome complications
Selva Lima Obesity its gynecological endocrine repercussion
Cuauhtemoc Celis-Gonzalez MHT: risks and benefits
Gerardo Broutin Conclusions
Lidia Sosa Conclusions

Onice Oral Presentation 09:45 ￫ 11:15
Amenorrhea and stress related hypothalamic disorders

Chairperson/s: Metella Dei , Laura Gaspari

Fabio Cesar Prosdocimi Effects of sex steroids on serum prolactin concentration in mice with metoclopramide-induced hyperprolactinemia
Antonio Mancini Oxidative stress as a link between hormonal picture and bone turnover in hypothalamic amenorrhea
Francesca Parissone Fertility preservation in a young woman with Turner-like phenotype due to chromosomic aberration
Anna Loktionova Diagnostic value LH and FSH levels in female patients with central hypogonadism
Aikaterini Giannouli Two interesting cases of primary amenorrhea with double pathology
Diletta Mauro Effects of estroprogestin therapy on premenstrual exacerbation of meniere’s disease
Anna Dittfeld The Use of Steroids by Gym Athletes: an Attempt to Diagnose the Problem Scale and Possible Causes
Aikaterini Giannouli Metabolic burden in adolescents with secondary Functional Hypothalamic Amenorrhea: is the risk real?
Vasileios Karountzos Total body fat mass combined with its distribution to trunk can predict menstrual recovery and positively influence the psychopathology of adolescents with Anorexia Nervosa
Dmitry Gusev A new index for the differential diagnosis of various forms of functional hypothalamic amenorrhea

Sala 4 Oral Presentation 09:45 ￫ 11:15
Endocrine disorders and other pathologies: impact on reproductive function

Chairperson/s: Mario Maggi , Antonio S. Laganà

Anna Kostrzak Bone mineral density in women with hyperprolactinaemia.
PINAR BAHAT Effects of neural therapy in patients with abnormal (dysfunctional) uterine bleeding
Faina Guseinova The characteristics of disorders of reproductive function in women with genital tuberculosis
Mónica Flores-Ramos Testosterone levels comparison between bipolar and depressed women.
Pedro Antonio Regidor Identification and prediction of the fertile window with a new web-based medical device using a vaginal biosensor for measuring the circadian and circamensual core body temperature
Sarah Johnson Failure to predict ovulation by Apps when applied to menstrual cycles of women trying to conceive
Svetlana Vorotnikova Features of pituitary-ovarian axis functioning in woman of reproductive age with acromegaly and Cushing’s disease.
Dimitrios Anastasios Bountouvas Spontaneous Conception After Hyperprolactinemia Treatment In Laron Syndrome Patient
Leonor Burgos Martínez Differences in gonadal hormone levels in women with treatment resistant depression and treatment responsive depression
Anna Dittfeld Epstein-Barr virus infection in patients with autoimmune thyroid disease
Ricardo Simoes Analysis of oxidative stress and apoptosis in the ovary of rats treated with soybean isoflavones
Anastasia Kudrytskaya Menstrual function and Endocrine Status in Kidney Transplanted Women

11:15 Thursday 8th

Break

11:45 Thursday 8th

Auditorium Symposium 11:45 ￫ 13:15
Estetrol and Breast Cancer

Chairperson/s: Nicoletta Biglia , Herjan Coelingh Bennink

Richard J. Santen Estetrol in animal in vivo studies
Risto Erkkola Estetrol in ex vivo explant cultures of human breast cancer tissue
Herjan Coelingh Bennink Estetrol treatment of advanced breast cancer

Affari 1 Symposium 11:45 ￫ 13:15
Urogenital aging

Chairperson/s: Farook Al-Azzawi , Pierluigi Benedetti Panici

Nick Panay Impact and management of VVA / GSM – an evidence based approach
Tomi Mikkola Stress urinary incontinence risk in women using HRT
Camil Castelo Branco VVA in young women
Tommaso Simoncini Managing pelvic organ prolapse between hormones and surgery

Affari 2 Symposium 11:45 ￫ 13:15
Reproductive impairment: from nature to therapies

Chairperson/s: Jonathan Ramsay , Moncef BenKhalifa

Alessandro D. Genazzani Stress and hypothalamic amenorrhea
Rossella E. Nappi New therapies for Impairment of female sexual desire
Gian Maria Busetto Male reproductive failure: how to face

Verde Symposium 11:45 ￫ 13:15
Cardiovascular protection and life long risk factors: diagnosis and management

Chairperson/s: Sven Skouby

Irene Lambrinoudaki Obstetrical history and cardiovascular risk in later life
Sven Skouby HT: pharmacology tailored to women’s health
Antonio Cano Symptoms and hormones: fine-tuning atherosclerotic risk ?
Peter Collins Cardiovascular risk management in women – an update, what’s new ?

Affari 4 Scientific Society Symposium 11:45 ￫ 13:15
Obesidad y su impacto en la salud reproductiva de la mujer – Organized by the Federacion Latina de Endocrinología Ginecologica (FLEG)

Chairperson/s: Nestor Siseles , Rafael Camacho

Greta Solis Epidemiology of overweight in Latin American women
Manuel Noelting Obesity: its impact on the menstrual cycle
Gustavo Gomez SOA, obesity and insulin resistance
Pablo Lavin Obesidad en mujeres en edad del climaterio
Gustavo A. Maciel Low grade chronic inflammation in brasilian obese PCOS
Javier Saavedra Trigliceridos y HDL. Importancia en DX y tratamiento de dislipidemias

Onice Oral Presentation 11:45 ￫ 13:15
Pregnancy: abortion and recurrent pregnancy loss

Chairperson/s: Gian Carlo Di Renzo , Bruno Mozzanega

Gaurav Desai Second Trimester Medical Termination of Pregnancy with Combined Intracervical and Intravaginal Misoprostol: Comparative Analysis with Intravaginal Misoprostol-A Pilot Study.
Agnieszka Dubiel The prevalence of MTHFR gene mutation in AITD women with history of miscarriage
Irina Zhukova Pro- and antiapoptotic proteins BCL-2 and Bax in endometrium of patients with miscarriages.
Alana Agnaeva Role of NK cells in early reproductive losses
Natasha Kashyap Role of altered Notch signalling in the pathogenesis of recurrent pregnancy loss (RPL): A northeast Indian cohort based pilot study
Margarita Bakleicheva The role of vitamin D for threatened miscarriage in the first trimester of pregnancy
Irina Zhukova Intracellular pattern-recognition receptors, recognizing viruses, in pathogenesis of missed and spontaneous abortions.
Elena Khazova Two seasons of the level of calcidiol in pregnant women of St. Petersburg.
Anjuma Begum Role of low vitamin d3 levels and linked deregulated placental apoptosis in recurrent pregnancy loss (RPL) pathogenesis: a study from northeast India
Amélie Keller Concentration of vitamin d from neonatal dried blood spots and the relation to gestational age, birthweight and ponderal index: the d-tect study

Sala 4 Oral Presentation 11:45 ￫ 13:15
Assisted Reproduction Technologies: from induction of ovulation to endometrial receptivity therapies

Chairperson/s: Jacques Cohen , Alberto Revelli

Maria Costanza Chiti A tailored protocol for human ovarian follicle isolation for clinical application
samir Elsayed Higher Body Mass Index Significantly Affects Intracytoplasmic Sperm Injection Success Rate
Leila Nazari Effects of autologous platelet-rich plasma in repeated implantation failure: a randomized controlled trial
AISHA ELBAREG Efficacy of Letrozole (LE) Combined with Cabergoline (CE) in Comparison to LE alone in ovulation induction among patients with Polycystic Ovarian Syndrome (PCOS) and Hyperprolactinemia (HP): Our Experience
Natalia Pasman Regulatory T cells in the ovarian follicular fluid of infertile women
Vladimir Zuev REGENERATION OF ATROPHIC ENDOMETRIUM IN ART PROGRAMS. EFFECT OF PHOTOTHERAPY. LONG-TERM RESULTS.
Anastasia Beta Clomiphene Citrate in addition to gonadotropins may improve ovarian response in poor responders
Miguel Estrada Supplementation of exogenous LH in patients with poor ovarian response in controlled ovarian stimulation.
Mirela Iancu Does vitamin D influence the in vitro fertilization outcome?
Livia Munhoz Does high progesterone levels on ovarian stimulation cycles damage the quality oocytes collected?
Loris Marin The impact of thyroid autoimmunity on embryo quality in women undergoing assisted reproductive technology.
Lu Wang DAF promotes endometrial cells proliferation and motility under ovarian hormone stimulation
Oxana Melkozerova Tissue and molecular effects of the cavitated solution in the endometrial receptivity rehabilitation of patients with the uterine infertility

12:00 Thursday 8th

Affari 0 Sponsored Key Lecture 12:00 ￫ 12:30

12:45 Thursday 8th

Affari 0 Sponsored Key Lecture 12:45 ￫ 13:15

13:30 Thursday 8th

Affari 1 Sponsored Lunch Symposium 13:30 ￫ 15:15

Affari 0 Sponsored Lunch Symposium 13:30 ￫ 15:15

15:15 Thursday 8th

Break

15:45 Thursday 8th

Auditorium Meet the Experts 15:45 ￫ 16:45
Should we re-think the role of gonadotrophins after the menopause?

Chairperson/s: Philippe Bouchard

Tommaso Simoncini Gonadotrophins and breast cancer
Xiaodong Fu Gonadotrophins and cardiovascular disease

Affari 1 Sponsored Meet the Experts 15:45 ￫ 16:45

Affari 0 Meet the Experts 15:45 ￫ 16:45
Stress and reproduction

Chairperson/s: Anna Maria Paoletti

Sarah Berga Does stress causes infertility?
Alessandro D. Genazzani Integrative treatment to overcome the neuroendocrine impairment

Affari 2 Sponsored Meet the Experts 15:45 ￫ 16:45

Verde Sponsored Meet the Experts 15:45 ￫ 16:45

Affari 4 Meet the Experts 15:45 ￫ 16:45
Ovarian tumors

Chairperson/s: Javier Domingo

Manuel Nölting Androgen secreting tumors
Pierluigi Benedetti Panici Update on cytoreductive surger for advanced ovarian cancer

Onice Oral Presentation 15:45 ￫ 16:45
Endometrial Hyperplasia and Endometrial Cancer

Chairperson/s: Massimiliano Fambrini , Attilio Di Spiezio Sardo

Chunlin Su Effect and evaluation of hysteroscopy on Fertility-preserving Treatment of endometrial atypical hyperplasia and early endometrial adenocarcinoma in PCOS patients ï¼ša retrospective study
Xing Wei Effect of electric field on endometrial adenocarcinoma cell and NO secretion
Cristina Benetti-Pinto The use of tamoxifen as a malignancy risk in women with endometrial polyp
Tamara Knific Sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer
Madina Dumanovskaya Atypical endometrial hyperplasia is always equivalent refers to endometrial intraepithelial neoplasia, whereas it is not always endometrial intraepithelial neoplasia refers to atypical endometrial hyperplasia
Mariami Andguladze Endometrial Hyperplasia – New Vector of Treatment
Huixiao Wang Effects of 17β-estradiol on endometrial cancer cell proliferation and HOTAIR expression
Chunlin Su Reverse of Endometrial Atypical Hyperplasia and Early endometrial carcinoma in PCOS women by Dydrogesterone plus Metformin:a pilot study
Gonda Konings Blocking 17β hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach

Sala 4 Oral Presentation 15:45 ￫ 16:45
Gynecological Surgery

Chairperson/s: Liselotte Mettler , Marie-Madeleine Dolmans

Gaurav Desai Robotically assisted hysterectomy for staging endometrial cancer: Experience at a tertiary care institution in India
Gianluca Damiani Comparison of the perioperative outcomes of vessel sealing instrument –assisted technique hysterectomy with conventional hysterectomy
Anna Rosner-Tenerowicz The assessment CO2 laser treatment of vulvovaginal atrophy and its influence on urine incontinence
Mariana Rebeca Garcia Elias Laparoscopic neovagina creation by davydov’s procedure: evaluation of the vaginal function and sexual satisfaction with follow-up to one year.
Bakhodir Kurbanov Improved surgical technique to treatment of genital prolapse.
Salvatore Giovanni Vitale Transvaginal bilateral sacrospinous fixation after second recurrence of vaginal vault prolapse: anatomical and functional outcomes, quality of life and sexual function.

16:45 Thursday 8th

Auditorium Symposium 16:45 ￫ 18:15
Premature Ovarian Insufficency

Chairperson/s: Camil Castelo-Branco , Walter Rocca

Farook Al-Azzawi Determinants of oocytes reserve and depletion
Nick Panay POI: progress through a global registry
Bart CJM Fauser POI: implications for cardiovascular health
Svetlana Vujovic Hypoestrogenism and insulin resistance in premature ovarian insufficiency: is it time dependent?

Affari 1 Symposium 16:45 ￫ 18:15
Fertility preservation: possibilities and strategies

Chairperson/s: Christian Egarter , Antonio Lanzone

Zion Ben Rafael The dilemma of social freezing
Marie-Madeleine Dolmans Ovarian tissue cryopreservation and transplantation: which success for 2018 ?
Javier Domingo Oocyte cryopreservation or tissue transplantation for fertility preservation in cancer patients: what is best ?

Affari 0 Symposium 16:45 ￫ 18:15
The role of exogenous sex hormones in pregnancy (Organized by the PREIS School Academy session)

Chairperson/s: Gian Carlo Di Renzo , Peter Platteau

Peter Platteau Role of exogenous sex hormones in medically assisted pregnancy
Mary Stephenson Role of sex hormones in recurrent pregnancy loss
Paul Piette The basics of progestogens and estrogens
Gian Carlo Di Renzo Role of exogenous sex hormones in perinatal period and on the preterm new born

Affari 2 Sponsored Symposium 16:45 ￫ 18:15

Verde Symposium 16:45 ￫ 18:15
Menopausal transition

Chairperson/s: Antonio Cano , Susan Davis

Tommaso Simoncini Neuroendocrine changes of the menopausal transition
Pauline Maki Cognition and hot flashes: a scientific update
Mary Ann Lumsden Following Guidelines – what should we say to those with heart disease ?
Santiago Palacios Effects and management of the menopausal transition on vulvo-vaginal tissue

Affari 4 Oral Presentation 16:45 ￫ 18:15
Polycystic Ovary Syndrome

Chairperson/s: Manuel Noelting , Andrea Giannini

Shahnoza Kalanhodjaeva Comparative analysis of clinical and hormonal parameters in women with hyperandrogenemia adrenal and ovarian genesis
Geranne Jiskoot Effects on body weight of a 1-year three-component lifestyle RCT in obese PCOS women.
Gokce Anik Ilhan Cardiotrophin-1 as a new metabolic biomarker in women with PCOS.
Elene Asanidze Anti-Mullerian Hormone is a Useful Marker for the Assessment of the Treatment Efficiency in Patients with Polycystic Ovary Syndrome (PCOS)
Adam Czyzyk Evolving endocrine and metabolic milieu of PCOS with aging
Mariana Paulson Endometrial expression of anti-müllerian hormone and its receptor in obese women with PCOS- a lifestyle intervention study
Szilvia Csehely Laboratory and etiology characteristics of PCOS phenotypes
Rhea Jabbour Assessment of carotid intima-media thickness in patients with polycystic ovary syndrome and its association with hormonal and lipid profiles
Chiara Sabbadin Vitamin D deficiency in polycystic ovary syndrome
Aleksandra Atanasova Boshku Lipid Accumulation Product (LAP), Waist to Hip Ratio (WHR) and Waist Circumference to Height Ratio (WGtR) associated with hormonal profile in women with Polycystic ovary syndrome
Aleksandra Atanasova Boshku Hyperandrogenemia and lipid profile in women with polycystic ovary syndrome
Hilma Lubis Fibrinolytic Activity in Woman with Polycystic Ovary Syndrome (PCOS)
Swati Sharma evaluation of effect of vitamin D supplementation on serum AMH in vitamin D deficient PCOS women

Onice Oral Presentation 16:45 ￫ 18:15
Endometriosis: ethiology and pathogenesis

Chairperson/s: Giuseppe Morgante , Silvia Vannuccini

Tianjiao Pei miR-194-3p represses the progesterone receptor and decidualization in eutopic endometrium from women with endometriosis
Manijeh Mehdinejad Endometriosis and adenomyosis in adolescents, fertile and menopausal women
Lutz Konrad Endometrium and Endometriosis – It is all the same from a cellular perspective
Antonella Biscione DHEA and DHEA-S concentrations in plasma and saliva samples of women affected by endometriosis
Yana Aznaurova Transcriptomic data of eutopic endometrium as a basis for a minimally invasive test of endometriosis.
Maša Sinreih AKR1C3 levels in ovarian, peritoneal and deep infiltrating endometriosis
Javier García Solares The concept of invasion in deep nodular endometriosis.
Li Xiao miR22-5p targets TET2 and regulates the Estrogen receptor 2 expression in infertile women with mild or minimal endometriosis during implantation window

Sala 4 Oral Presentation 16:45 ￫ 18:15
Breast Cancer

Chairperson/s: Risto Erkkola , Christian Singer

Christel Pequeux Dose-dependent effect of estetrol (E4) on mammary gland and breast cancer: an opportunity for new menopause treatments
Ambrogio P Londero Breast cancer development in patients with borderline breast lesions
Marina Willibald Progesterone Receptor Membrane Component-1 is Phosphorylated upon Progestin Stimulation and Binds to Estrogen Receptor α-Coregulators PHB1 and PHB2 in Breast Cancer Cells
Marina Willibald PGRMC1 Promotes Tumour Progression of Breast Cancer through Upregulation of ERα Expression and EGFR signalling
Anna Rasmussen Adult granulosa cell tumor associated with breast cancer in Denmark 1964-2016
Foteini Anifantaki Hormone receptor expression in pregnancy- associated breast cancer: a systematic review of the literature
Vanessa Trindade Evaluation of ovarian function in young women after breast cancer chemotherapy treatment
Xiaosa Li GPER1 Promotes Estrogen Receptor Negative Breast Cancer Cells Migration and Invasion via Nongenomic Activation of c-Src/NF-κB/Focal Adhesion Kinase Cascade

18:15 Thursday 8th

Auditorium ISGE General Assembly 18:15 ￫ 19:30
ISGE General Assembly

Affari 1 Scholarship Course 18:15 ￫ 19:30
Scholarship Course

Howard Carp Obstetric Endocrinology
Richard J. Santen Hormones and Cancers

Friday 9th March 2018

08:30 Friday 9th

Auditorium Meet the Experts 08:30 ￫ 09:30
Progesterone and SPRMs effects on endometrium for decidualization and receptivity

Chairperson/s: Anna Glasier

Fernando Reis Progesterone-induced paracrine factors in human endometrium: the key for decidualization and receptivity
Bruno Mozzanega Ulipristal and the human endometrium: : the case of Emergency contraception

Affari 1 Meet the Experts 08:30 ￫ 09:30
The vaginal and endometrial microbiota

Chairperson/s: Svetlana Vujovic

Gary Ventolini Intravaginal and endometrial microbiota are important for human reproduction
Inmaculada Moreno Study of the endometrial microbiota to improve ART outcomes

Affari 0 Corso Superiore di Ginecologia Endocrinologica AIGE 08:30 ￫ 11:30
Management della Terapia Ormonale Sostitutiva

Chairperson/s: Carmine Nappi

Rossella E. Nappi Sintomi climaterici come marker di vulnerabilità biologica
Anna Maria Paoletti Quando integrazione e quando sostituzione ormonale
Vincenzo De Leo PCOS e menopausa: nuove opzioni terapeutiche
Angelo Cagnacci L’evoluzione della TOS: combinata ciclica o continua, steroidi di sintesi o TSEC

Affari 2 Scientific Society Symposium 08:30 ￫ 09:30
Gynecological surgery: from complications to new possibilities – Organized by the International Academy of Human Reproduction (IAHR)

Chairperson/s: Leila Adamyan , John Sciarra

Liselotte Mettler Fibroids and malignancy potentials in reproductive surgery
Joseph Schenker Complications of ART technology
Andrea Giannini, Tommaso Simoncini Horizons in gynecologic robotic surgery

Verde Scientific Society Symposium 08:30 ￫ 09:30
Hot topics in Gynecological Endocrinology – Organized by the Polish Society of Gynecological Endocrinology

Chairperson/s: Blazej Meczekalski , Andrzej Milewicz

Grzegorz Breborowicz Obesity – what kind of problem it is in contemporary perinatology?
Agnieszka Podfigurna Hyperandrogenism related to androgen secreting ovarian tumors
Krzysztof Lukaszuk Endometrial receptivity and luteal phase support
Blazej Meczekalski Fertility in women of late reproductive age

Affari 4 Scientific Society Symposium 08:30 ￫ 09:30
Aspects related to middle-aged women – Organized by the Asociacion Argentina para el estudio del Climaterio (AAPEC)

Chairperson/s: Rita Caro , Elida Rodriguez

Claudia Rey Osteopenia: when and how to intervene?
Monica Nanez Are local hormones really important in genitourinary urinary tract?
maria belardo Sleep disorders in perimenopausal women, and metabolic syndrome
Blanca Campostrini Treatments for menopausal symptoms: which are the best options.?
Cristina Montero Discussion

Onice Scientific Society Symposium 08:30 ￫ 09:30
Male Contraception under the auspices of ICMC – Organized by the International Consortium for Male Contraception (ICMC)

Chairperson/s: David Serfaty , Regine Sitruk-Ware

David Serfaty Activities and update of ICMC
Cristina Meriggiola Overview on male hormonal contraception
Regine Sitruk-Ware Possible non contraceptive benefits of hormonal male contraception
Mario Festin WHO efficacy study on male contaception: last update

Sala 4 Oral Presentation 08:30 ￫ 09:30
Gynecological Cancers

Chairperson/s: Massimo Stomati , Franco Borruto

Giorgio Bogani Potential Implication on the Introduction of the Nonavalent Vaccination Against HPV: an analysis HPV prevalence in 13,665 patients over a 18-year study period
Maria Luisa Gasparri Immune response to Chemotherapy-Associated Antigens as preoperative predictor of oncologic outcome in Ovarian Cancer patients: a pilot study
Hexia Xia Follicle loss and PTEN/PI3K/mTOR signaling pathway activated in LepRb-mutated mice
Alexandra Asaturova Innovative liquid-based cytology of fallopian tube smears in intraepithelial precancerous lesions diagnostics
Anna Protasova Safety of prescribing MGT after successful treatment of CIN and squamous cell carcinoma of the cervix.
Bruna De Almeida Expression of miR-148a, miR-152 and miR-21 and genetic interactions network in uterine leiomyosarcoma cells
Giorgio Bogani Introducing Nerve-Sparing Approach during Minimally Invasive Radical Hysterectomy for Locally-Advanced Cervical Cancer: A multi-Institutional Experience

09:45 Friday 9th

Auditorium Symposium 09:45 ￫ 11:15
Neurosteroids as regenerative agents

Chairperson/s: Cordian Beyer , Luis M. Garcia-Segura

Roberta Brinton Diaz Allopregnanolone as a therapeutic to regenerate the degenerating brain
Michael Schumacher Progesterone and stroke
Regine Sitruk-Ware Effects of progesterone and nestorone on myelin

Affari 1 Scientific Society Symposium 09:45 ￫ 11:15
Alternative treatment methods of patients with benign tumors and hyperplastic processes of the uterus in women of reproductive age- Organized by the Russian Society of Reproductive Medicine and Surgery

Chairperson/s: Leila Adamyan , Vladimir N. Serov

Leila Adamyan Management of patients with uterine fibroids from the age perspective
Vitaly Bezhenar Combined hyperplastic processes of the organs of reproductive system in women with infertility
Victoria Kasyan Medical aspects of contraception
Galina Chernukha PCOS and infertility
Elena Andreeva Role of the gynecologist in the detection of benign breast tumors from the perspective of cancer prevention

Affari 2 Sponsored Symposium 09:45 ￫ 11:15

Verde Symposium 09:45 ￫ 11:15
PCO: genetic, epigenetic and metabolic risk factors

Chairperson/s: Xiangyan Ruan , Basil Tarlatzis

Jerome Strauss Genetic and epigenetic factors contributing to the hyperandrogenemia of PCOS
Charles Sultan Adolescent PCOS: an entity?
Alessandro D. Genazzani Metabolic impairment and new therapeutic strategies for PCOS
Andrzej Milewicz Serum bisphenol A and metabolic profile in women with PCOS
Archil Khomasuridze PCOS: the new approach

Affari 4 Scientific Society Symposium 09:45 ￫ 11:15
Clinical challenges in the menopause transition – Organized by the Latino-American Federation of Climateric and Menopause Societies (FLASCYM)

Chairperson/s: Sonia Cerdas , Zully Benitez

Sonia Cerdas The endocrinology of menopause transition
Nestor Siseles Risks and indications of contraception
Alejandro Paradas Achieving pregnancies during MT
Maria Teresa Espinoza Hot flashes and migraines approach
Silvina Witis Management of abnormal bleeding
Cuauhtemoc Celis-Gonzalez Bone health during MT
Alejandra Elizalde Cremonte Questions and closing remarks
Greta Solis Questions and closing remarks
Maria Alejandra Schuele Questions and closing remarks

Onice Scientific Society Symposium 09:45 ￫ 11:15
Role of progestogens in women’s health: an up-date – Organized by the European Progestogen Club (EPC)

Chairperson/s: Adolf E. Schindler , René Druckmann

Pedro-Antonio Regidor Role of progestogens in women’s health: an update. Clinical relevance in present day hormonal contraception
Alfred Mueck Choice of progestogen for HRT in menopausal women
Sven Skouby Impact of progestogenes on hemostasis
Nicola Pluchino Brain progesterone metabolite: Allopregnanolone production and its regulation
Vitaly Tskhay Results of hormone therapy and recovery of the patients with severe forms of adenomyosis

Sala 4 Oral Presentation 09:45 ￫ 11:15
Menopause: vascular effects and cardiovascular diseases

Chairperson/s: Damir Franic , Margaret Rees

Alfred Mueck Vasodilative potency induced with Estradiol in women with and without CAD during standardized stress:- two parallized, randomized, double-blind, placebo-controlled cross-over studies
Anna Dalla Cà Acute effect of estrogens stimulation -triptorelin induced on heart ECG parameters in patients with polycystic ovary syndrome
Tord Naessen Improved inflammation markers during menopausal hormone therapy correlate to ultrasonographic signs of vascular benefit. – a randomized-controlled study
Yizhou Huang Function and mechanism of estrogen in regulating vascular endothelial barrier
Anne Gallez Inclusion of 17β-estradiol into liposome: a new tool to study the molecular mechanisms of estrogen receptors
Mahsa Noroozzadeh The effect of prenatal exposure to a single dose of testosterone on cardiac function of male and female rats in adulthood
Cindy Meun High androgen levels in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study
Ping Li 17b-Estradiol Enhances Vascular Endothelial Ets-1/ miR-126-3p Expression: The Possible Mechanism for Attenuation of Atherosclerosis
Eleni Armeni The TYG index as a potential predictor of subclinical vascular disease after the menopause
Hai Jiang Changes in cardiovascular function based on adrenalin and norepinephrine metabolism in ovariectomized rats
Hai Jiang Proteomics in plasma of ovariectomized rats and those exposed to estradiol valerate

11:15 Friday 9th

Break

11:45 Friday 9th

Auditorium Symposium 11:45 ￫ 13:15
Neuroprotection

Chairperson/s: Roberta Brinton , Michael Schumacher

Luis Garcia-Segura Neuroprotective action of estradiol and estrogen receptors
Walter Rocca Sex, gender, and the decline of dementia
Andrea R. Genazzani Adrenal androgens impact on neurosteroids
Cordian Beyer Estradiol control of brain inflammation and pyroptosis

Affari 1 Symposium 11:45 ￫ 13:15
Androgens

Chairperson/s: Duru Shah , Jerome Strauss, III

Charles Sultan Management of adolescent hyperandrogenism: still a challenge !
Angelica Hirschberg The role of androgens for body composition and physical performance in women
Susan Davis Testosterone and cardiovascular health after menopause, a benefit or risk?
Zana Bumbuliene Hyperandrogenism in adolescents

Affari 2 Symposium 11:45 ￫ 13:15
Osteoporosis: a long life risk for women

Chairperson/s: Mark Brincat , Faustino Perez-Lopez

Martin Birkhaeuser Prevention of osteoporosis in anorexia nervosa: what is new?
John Stevenson HRT for prevention of osteoporosis
Tobias De Villiers New drug development in osteoporosis

Verde Symposium 11:45 ￫ 13:15
Endometriosis/Adenomyosis: from basic science to clinics

Chairperson/s: Leila Adamyan , Luigi Devoto

Caterina Exacoustos The role of transvaginal U/S in the diagnosis of endometriosis and adenomyosis
Ludwig Kiesel Regulation of proliferation and invasion in endometriosis
Robert Taylor Cell biology of nascent endometriosis implants
Nicola Pluchino Role of bone marrow-derived cells in endometriosis development

Affari 4 Scientific Society Symposium 11:45 ￫ 13:15
Management of healthy ageing – Organized by the European Menopause and Andropause Society (EMAS)

Chairperson/s: Tommaso Simoncini , Irene Lambrinoudaki

Michael van Trotsenburg Aging in Transgender Men and Women
Margaret Rees Diet and lifestyle interventions for midlife health and beyond
Alfred Mueck Impact of menopausal hormone therapy on morbidity and mortality
Antonio Cano () Concept of healthy ageing according to EIP on AHA

Onice Oral Presentation 11:45 ￫ 13:15
Assisted Reproduction Technologies: predictive markers, OHSS and ethical aspects

Chairperson/s: Inmaculada Moreno , Elisabetta Coccia

Giulia Murru Plasmatic androgens as predictors of ovarian response in ART: a prospective cohort study.
Antonio Mancini Infertility as an indication for provocative testing of Growth Hormone
Svetlana Zhukovskaya Prognostic markers of ovarian hyperstimulation syndrome in assisted reproductive technologies
Amerigo Vitagliano Endometrial scratch injury before intrauterine insemination: Is it time to re-evaluate its value? Evidence from a systematic review and meta-analysis of randomized controlled trials.
Piyush Bansal The role of GnRH analogues(GnRH-a) in improving outcome in women undergoing super-ovulation (SO) and intra-uterine insemination (IUI) after surgical correction of minimal to mild endometriosis: a randomized control trial.
Diana Mihai What to do with the surplus cryopreserved embryos? The view in accordance with the principles of bioethics
Parnaz Borjian Boroujeni Thrombophilic genes alterations as risk factor for OHSS
Tiffanny Jones Lavender aromatherapy to reduce anxiety during intrauterine inseminations: a randomized, controlled trial
Taisiia Yurchuk Multiple pregnancy rate and single transfer of either fresh or cryopreserved embryo.

Sala 4 Oral Presentation 11:45 ￫ 13:15
Pre-Eclampsia and Pregnancy Induced Hypertension

Chairperson/s: Fernando Reis , Filiberto Severi

Tetiana Loskutova New approaches to the prognosis of preeclampsia in pregnant woman
Dorota Darmochwal-Kolarz The role of Placental Growth Factor and Endoglin in the pathogenesis of pre-eclampsia
Lucia Maria Procopciuc Newborn genotypes associated with endothelial dysfunction as a risk factor for mild and severe preeclampsia
Svetlana Dubrovina Early predictors of late-onset preeclampsia
Marta Hentschke Alterations and association in Endocan-1 and placental growth factor in women with pre-eclampsia
Lutfiya Karimova Genes of vascular tone polymorphism and PE risks in Uzbek population
Natalya Yakovleva Matrix metalloproteinase-12 is a predictor of pre-eclampsia?
Anna Drobintseva Placental kisspeptin and annexin V protein expression in preeclamptic pregnancies
Fabio Barra Incidence of pregnancy induced hypertension (PIH) and small-for-gestational-age (SGA) infants in oocyte-donation (OD) pregnancies: a prospective comparative study
Sapiyat Ibragimova Markers for prediction early and late preeclampsia and fetal development delay
Umida Ashurova Polymorphism of candidate genes associated with the risk of developing gestational hypertension

12:00 Friday 9th

Affari 0 Sponsored Key Lecture 12:00 ￫ 12:30

12:45 Friday 9th

Affari 0 Sponsored Key Lecture 12:45 ￫ 13:15

13:30 Friday 9th

Affari 1 Sponsored Lunch Symposium 13:30 ￫ 15:15

Affari 2 Lunch Symposium 13:30 ￫ 15:15
Evolution in contraception in 2018

Chairperson/s: Santiago Palacios

Rossella E. Nappi Evolution in contraceptive vaginal rings
Illam Baram Evolution in intrauterine contraception

15:15 Friday 9th

Break

15:45 Friday 9th

Auditorium Key Lecture 15:45 ￫ 16:15
Only Estrogen-Only is good for Breast Cancer

Chairperson/s: Anne Gompel

Herjan Coelingh Bennink Only Estrogen-Only is good for Breast Cancer

Affari 1 Key Lecture 15:45 ￫ 16:15
Endometriosis and adenomyosis in adolescents, fertile and menopausal women

Chairperson/s: John Sciarra

Leila Adamyan Endometriosis and adenomyosis in adolescents, fertile and menopausal women

Affari 0 Key Lecture 15:45 ￫ 16:15
The ovarian renin-angiotensin system

Chairperson/s: Jean Michel Foidart

Frederick Naftolin The ovarian renin-angiotensin system

Affari 2 Key Lecture 15:45 ￫ 16:15
Current perspectives on the management of Uterine Fibroids

Chairperson/s: Andrea R. Genazzani

Jacques Donnez Current perspectives on the management of Uterine Fibroids

Verde Key Lecture 15:45 ￫ 16:15
Stress, emotional eating, and reproductive function

Chairperson/s: Bruno Lunenfeld

Sarah Berga Stress, emotional eating, and reproductive function

16:30 Friday 9th

Auditorium Symposium 16:30 ￫ 18:00
Breast cancer: clinical impact of latest investigations

Chairperson/s: Alfred Mueck , Stefanos Zervoudis

Nicoletta Biglia Breast cancer screening today
Anne Gompel When can HT be used in those at increased risk of breast cancer ?
Xiangyan Ruan Membrane-bound-Progesterone-Receptor can predict prognosis of breast cancer
Christian Singer Endocrine therapy and fertility in young breast cancer patients

Affari 1 Symposium 16:30 ￫ 18:00
Depression and cognition in midlife women

Chairperson/s: Michèle Lachowsky , Pauline Maki

Luis Garcia-Segura Estrogenic regulation of neuro-inflammation: implications for depression and cognition
Alessandra Graziottin Osteoarthritis: a neglected trigger of neuroinflammation and depression in women
Tory Eisenlohr-Moul Novel methods for clarifying the psychiatric effects of ovarian steroids across the female lifespan
John Studd Estrogens and testosterone for reproductive depression

Affari 0 Symposium 16:30 ￫ 18:00
Cardiovascular protection: the sex steroids challenges

Chairperson/s: Irene Lambrinoudaki , Peter Collins

Frederick Naftolin Sex steroids block the initiation of atherosclerosis
John Stevenson HRT for primary prevention of CHD
Nestor Siseles Cardiovascular risk in climacteric women: when to begin the hormone treatment ?
Tomi Mikkola Cardiovascular mortality risk and HRT

Affari 2 Symposium 16:30 ￫ 18:00
Early pregnancy: a critical period with multiple affecting factors

Chairperson/s: Tomoyuki Fujii , Mary Stephenson

Takeshi Maruo Thyroid hormone in trophoblast invasion and early pregnancy maintenance
Howard Carp Management of antiphospholipid syndrome in pregnancy
Robert Taylor Gap junctions and hormonal regulation of endometrial decidualization
Mark Brincat The IVF/ICSI, early pregnancy interphase

Verde Symposium 16:30 ￫ 18:00
Contraception: personalized regimens, new molecules

Chairperson/s: Nilson R. De Melo , Angelica Hirschberg

Anna Glasier The advantages and disadvantages of long-acting reversible contraception (LARC)
Johannes Bitzer Do will still need anti-androgenic progestogens?
Adolf Eduard Schindler The role of progestogen-only-pills (POP’s) for contraception and non-contraceptive indications
JEAN MICHEL FOIDART Introducing the first NEST in contraception (native estrogen with selective tissue activity)

Affari 4 Oral Presentation 16:30 ￫ 18:00
Vulvo-Vaginal Atrophy , Bone effects and other Menopause symptoms

Chairperson/s: Santiago Palacios , Tobias De Villiers

Emilia Berin Resistance training for hot flushes in postmenopausal women
Simin Taavoni Effect of Valerain Capsules on Menopausal Symptoms: A Triple Blind Randomized Clinical Trial
Sebastian Mirkin Symptomatic vulvar and vaginal atrophy (VVA) relief was achieved with TX-004HR, an investigational vaginal estradiol softgel capsule, with negligible to very low systemic absorption of estradiol: PK comparison with systemic and a vaginal estradiol
Zorana Arizanovic Vasomotor symptoms and blood pressure in menopausal women
Muhammad Fidel Ganis Siregar Relationships of Cognitive Function Based on Informant Questionaire Cognitive Decline (IQCODE) in the elderly with serum estradiol levels on paramedic with menopause age in Indonesia
Thomas Stevenson Effect of HRT on inter-vertebral disc height: data from a prospective randomised trial
Evaggelia Karopoulou Association between calcium metabolism and arterial stiffness in asymptomatic postmenopausal women.
Marta Caretto Effects of six-month oral dehydroepiandrosterone supplementation on beta-endorphin response to oral glucose tolerance test in obese and non-obese pre and postmenopausal women
Ana Osorio Ruiz The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review
Lubov V. Kuznetsova factors affecting the effectiveness of therapy of osteopenic syndrome in postmenopausal women
Svetlana Yureneva Vaginal symptoms and microbiotа in postmenopausal women
Irene Zolfaroli Plasmatic Lipids and bone, the link for new treatments

Onice Oral Presentation 16:30 ￫ 18:00
Pregnancy: gestational diabetes mellitus

Chairperson/s: Gary Ventolini , Paolo Mannella

Ofelia Bettikher The vascular reactivity to serotonin of human chorionic plate arteries in gestational diabetes, preeclampsia and both pregnancy complications
Fareha Fauzan Meta-analysis: Genetic Polymorphisms associated with Gestational Diabetes Mellitus
Diana-Elena Comandasu Pregnancy related diabesity and poor fetal outcome: the key role of inflammation
changling DUAN Pregnancy Complications of Polycystic Ovary Syndrome
Salvatore Giovanni Vitale Myo-inositol supplementation to prevent gestational diabetes and effects on body composition in overweight non-obese women: a randomized placebo-controlled trial
Polina Abramicheva Hyperprolactinemia in cholestasis of pregnancy is associated with decreased renal outer medulla Na+/K+-АТPase activity and elevation of pSTAT5
Deng Ao Early risk-prediction models of Gestational diabetes mellitus in Chinese women using support vector machine model
Swati Sharma Evaluation of association of vitamin D insufficiency with gestational diabetes mellitus
Alexandra Onopriychuk Markers of endothelial dysfunction and coagulation in gestational diabetes mellitus
Alexandra Onopriychuk Placental expression of the angiogenic growth factors in gestational diabetes mellitus
Joanna Marie Paulino-Morente Cerebral Cavernous Malformation Activated By Elevated Vascular Endothelial Growth Factor in Placenta, Gestational Diabetes Mellitus, and Hepatic Hemangioma in a Young Pregnant: A Case Report

Sala 4 Oral Presentation 16:30 ￫ 18:00
Endometriosis, DUB and Uterine Fibroids: symptoms and treatments

Chairperson/s: Stefano Angioni , Nicola Pluchino

Silvia Baggio Influence of ulipristal acetate therapy on uterine fibroid-related symptoms and on uterine and fibroid volume and vascularity indices assessed by ultrasound
Hugo Maia The Effect of the Association of Miodesin with Gestrinone on Deep Endometriosis Pain
Aleksandar Jurisic What can be expected from Ulipristal in the treatment of uterine fibroids?
Alexandra Mihaila Clinical and paraclinical considerations interesting the hormonal therapy in women with endometriosis
Roxana Matasariu Progesterone treatment in endometriosis- immunohystochemical variations
Roxana Matasariu impact of endometriosis on physical, mental and social wellbeing – a qualitative study
Ticiana Mira What else can we do? A complementary treatment for pain in deep endometriosis using electrotherapy
Arsenii Molotkov Aromatase inhibitors in treatment of endometriosis in experiment and clinical trial
Shara Borgato Uterine fibroids size modifications during pregnancy and puerperium: evidence from the first systematic review of literature.
Giovanni Grandi Dienogest influence on miRNA expression in tumor necrosis factor-α stimulated endometrial stromal cells from women with endometriosis

18:00 Friday 9th

Auditorium Symposium 18:00 ￫ 19:30
Precision medicine and hormone therapy: right woman, right time, right regimen.

Chairperson/s: Tomi Mikkola , John Stevenson

Roberta Brinton Diaz The perimenopause is personal: precision hormone therapy to make it precise
Pauline Maki A scientific update on the critical window of hormone therapy and cognition: who, what, when?
Regine Sitruk-Ware How to tailor progestin use to individual needs in the post-menopause
Andrea R. Genazzani How long to treat and how adapt the hormone therapy to the overcoming needs

Affari 1 Symposium 18:00 ￫ 19:30
Gynecological symptoms and psychosomatic health

Chairperson/s: Tory Eisenlohr-Moul , John Studd

Liliana Gazzuola Rocca Adverse childhood or adult experiences and gynecological symptoms
Tamaki Matsumoto-Takayanagi Autonomic nervous system activity and psychophysiological symptoms during the menstrual cycle
Michèle Lachowksy Endometriosis and infertility, a psychosomatic approach

Affari 0 Symposium 18:00 ￫ 19:30
PCO: ART and pregnancy outcomes

Chairperson/s: Pedro Barri , Luca Gianaroli

Basil Tarlatzis PCOS: what is the preferred stimulation protocol for IVF ?
Xiangyan Ruan Aromatase inhibitors plus HMG for infertile PCOS women
Duru Shah AMH in PCOS and ART outcome
Bart CJM Fauser Metabolic dysfunction in PCOS: implications for pregnancy and children outcomes

Affari 2 Symposium 18:00 ￫ 19:30
Sexuality all the life

Chairperson/s: René Druckmann , Alessandra Graziottin

Johannes Bitzer New sexualities – the internet and sex
Angelica Hirschberg Hormonal contraception and impact on sexuality
Rossella E. Nappi Genitourinary syndrome of menopause and impact on women’s life
Susan Davis Sexual wellbeing and older women- what is the data?

Verde Symposium 18:00 ￫ 19:30
Progesterone: the life time partner steroid

Chairperson/s: Howard Carp , Robert Taylor

Luigi Devoto Different pathways of P-receptor complex in the process of ovulation
Adolf Schindler Prevention or treatment of pregnancy disorders with progestogens
Philippe Bouchard Progesterone: friend and /or foe on breast and CNS
Alfred Mueck Vascular effects of progestogens

Affari 4 Oral Presentation 18:00 ￫ 19:30
Androgen Insensitivity Syndrome and Adolescent Polycystic Ovary Syndrome

Chairperson/s: Salvatore Caruso , Zana Bumbuliene

Takhmina Rasuleva LEPR p.Q223R polymorphism influences plasma leptin levels and body mass index in Uzbek obese women of childbearing age.
VERA ANDREEVA The role of Leptin and and soluble Leptin Receptor Levels in pathogenesis of ovarian dysfunction in adolescent girls with obesity
VERA ANDREEVA The role of Toll-like receptors in pathogenesis of insulin resistance and ovarian dysfunction in girls with obesity
Elena Khashchenko Mitochondrial Dysfunction and Oxidative stress activation in Adolescent Girls with Polycystic Ovary Syndrome and Excessive Body Weight
Sujata Kar Metformin versus OCP in adolescent PCOS girls: an RCT from India.
Giulia Gava Bone mineral density in women with complete androgen insensivity syndrome
Mukhlisa Shariksieva The occasion of 21CYP mutation in girls with premature adrenarche
Despoina Apostolaki No Differences in Serum Brain-Derived Neurotrophic Factor between Overweight/Obese and Normal Weight Adolescents with Polycystic Ovary Syndrome
Giovana Maffazioli Evaluation of Reproductive Function in a Rat Model of Genetic Epilepsy Absence Seizures
Vasileios Karountzos The role of Bulimia Nervosa in hormonal and metabolic profile, as well as in menstrual pattern, of overweight and obese adolescents
Mary Grace Villafuerte Mixed Germ Cell Tumor in Androgen Insensitivity Syndrome: A Case Report

Onice Oral Presentation 18:00 ￫ 19:30
Contraception

Chairperson/s: David Serfaty , Gabriele Merki

Melinda Vanya Differences in the use of contraception between Roma and non-Roma women in Hungary
Pedro Antonio Regidor Clinical development of Ornibel® a new generation etonogestrel/Ethinylestradiol vaginal ring: Comparative bioavailability and tolerability vs Nuvaring ®
Vitaly Tskhay Results of the operative surgery with severe forms of adenomyosis
Mohd Faizal Ahmad Combined oral contraceptive pills ( COCPs ) versus nsaids in management of bleeding irregularities among implanon users
Pedro Antonio Regidor Clinical development of Ornibel ® a new generation etonogestrel/ethinylestradiol vaginal ring: Comparative tolerability, acceptance and flexibility of the new ring with Nuvaring®
Joanna Kacperczyk-Bartnik Global trends in use of birth control methods
Albe Swanepoel Effect of two ethinyl estradiol and drosperinone containing combined oral contraceptives on whole blood clot viscoelasticity
GIULIA GAVA The impact of counselling and no-cost provision of LARCs in women with repeat abortions in Italy.
Muhammad Azrai Abu Vaginal bleeding irregularities and its perception among implanon users
Aditi Chauhan Sperm impairing factor from Staphylococcus aureus as male contraceptive: An in vivo study

Sala 4 Oral Presentation 18:00 ￫ 19:30
Assisted Reproduction Technologies: from maternal and paternal age impact to ovarian tissue transplantation

Chairperson/s: Cesare Aragona , Guido Ambrosini

Maria Costanza Chiti A novel fibrin-based matrix for the creation of an artificial ovary prototype for human application
Patrizia Monteleone Thyroid peroxidase identified in human granulosa cells
Beatriz Alvaro Mercadal Working out the best AMH threshold for a good ovarian response in oocyte donors
Georgios Scheiner-Bobis Physiological and pathophysiological relevance of ZIP9, a zinc transporter, androgen receptor, and G-protein-coupled signal transducer
Sava Micic DNA fragmentation index (DFI) and seminal carnitine, with moderate accuracy, impact progressive sperm motility in oligoasthenozoospermc men treated with metabolic and essential nutrients
Karina Cázarez Pérez Association between advanced paternal age, seminal quality and the dna fragmentation index
Ludmila Barbakadze The value of AMH, AFC and age for prediction of IVF outcome
Diego Daniel Manavella Two-step transplantation with adipose tissue-derived stem cells increases follicle survival by enhancing vascularization in xenografted frozen-thawed human ovarian tissue
Luciana Cacciottola In vivo characterization of metabolic activity and oxidative stress in grafted human ovarian tissue using microdialysis
MacKenzie Purdy Does the co-flare in-vitro fertilization (ivf) protocol change the number of oocytes retrieved for women with diminished ovarian reserve (DOR)?

Saturday 10th March 2018

08:30 Saturday 10th

Affari 1 Meet the Experts 08:30 ￫ 09:30
Population Council – ISGE Session: Novel options for women health protection

Chairperson/s: Rossella E. Nappi

Regine Sitruk-Ware Vaginal rings for dual protection
Anna Glasier Interventions to reduce unintended pregnancy rates

Affari 0 Corso Superiore di Ginecologia Endocrinologica AIGE 08:30 ￫ 11:30
Endometriosi e dolore pelvico cronico

Chairperson/s: Luigi Venturini

Stefano Luisi Le basi fisiopatologiche dell’endometriosi e le scelte terapeutiche
Stefano Angioni Chirurgia dell’endometriosi: quando e quanto radicale?
Antonio La Marca La paziente con endometriosi alla ricerca di una gravidanza: come procedere ?
Alessandra Graziottin Dolore pelvico cronico non da endometriosi : diagnosi e strategie terapeutiche

Affari 2 Meet the Experts 08:30 ￫ 09:30
Obesity and reproduction: impact in pregnancy and at menopause

Chairperson/s: Fabio Facchinetti

Eran Hadar Facing the Non Communicable Disease (NCD) global epidemic – it all starts in utero
Peter Chedraui The metabolic syndrome a pro-inflammatory state before or after the menopause?

Verde Scientific Society Symposium 08:30 ￫ 09:30
Women in her psychoneuroimmunoendocrinologycal universe – Organized by the Sociedad Argentina de Endocrinologia Ginecologica y Reproductiva (SAEGRE)

Chairperson/s: Manuel Noelting

Sandra Demayo PCOS, Insulin- resistant and mood disorder: an intricately overlapped story
Amalia Monastero Stress and the onset of oncological pathologies: the worst oulet
Susana Pilnik Transition to menopause: emotional vulnerability to falling hormones

Affari 4 Scientific Society Symposium 08:30 ￫ 09:30
New research in Chinese women – Organized by the Chinese Society of Gynecological Endocrinology

Chairperson/s: Xiangyan Ruan , Alfred Mueck

Xiangyan Ruan Ovarian tissue retransplantation in cancer patients first center in China
wei huang PCOS with metabolic disorders: Treatment wird insulin sensitizer and lifestyle change
Jinfang Lin Management of PCOS patients with endometrial hyperplasia and early adenocarcinoma

Onice Scientific Society Symposium 08:30 ￫ 09:30
Unmet needs in sexual care – Organized by the Federazione Italiana di Sessuologia Scientifica (FISS)

Chairperson/s: Vieri Boncinelli , Salvatore Caruso

Chiara Simonelli Female genital-pelvic pain disorders
Elena Lenzi Female sexual dysfunctions and couple-based clinical interventions
Salvatore Caruso No drug treatment for women with sexual dysfunction

Sala 4 Scientific Society Symposium 08:30 ￫ 09:30
Metabolic impact of the climacteric women (Organized by the Chilean Society of Gynecological Endocrinology (SOCHEG)

Chairperson/s: Patricio Barriga , Luigi Devoto

Sergio Brantes Clinical responses to the metabolic risk associated with the peri and post menopause
Pablo Lavin Metabolic Syndrome in Chilean women and their oncological risk in breast and endometrium
Marcela Lopez Hormonal and non-hormonal therapeutic strategies to reduce cardiovascular risk in women with high metabolic risk

09:45 Saturday 10th

Affari 1 Symposium 09:45 ￫ 11:15
Menopause: suggestions from nature

Chairperson/s: Cuauhtemoc Celis , Ludwig Kiesel

David Archer Novel treatment of vulvovaginal atrophy with prasterone:an approach based upon physiology
James Pickar Novel oral, continuous-combined solubilized 17β-estradiol and natural progesterone provides endometrial protection: Comparison of two randomized controlled trials
Ewald Boschitsch Menopause Hormone Therapy: the natural way is the safest!
Lydia Marie-Scemama Recent international recommandations about HRT: what impact on gynecologists and patients in 2018?

Affari 2 Symposium 09:45 ￫ 11:15
ART – Time is moving: new difficulties and new possibilities

Chairperson/s: Bart Fauser , Joseph Schenker

Luca Gianaroli 40 years after Louise Brown
Paolo Artini Collapse of blastocysts is correlated to implantation success or not ?
Pedro N. Barri Uterine factor in IVF repeated implantation failure

Verde Scientific Society Symposium 09:45 ￫ 11:15
Hormonal contraception – needs, possibilities and safety: the debate is still going on – Organized by the European Society of Gynecology (ESG)

Chairperson/s: Andrzej Milewicz , Mark Brincat

David Serfaty How to reduce unintended pregnancies and abortions
Johannes Bitzer Fertility control among populations living in poverty- an ethical taboo or an urgent necessity?
Ulisse Gaspard Numerous Progestins could be listed as Fourth Generation progestins
Sven Skouby Hormonal contraception: the ghost of pill scare still rides!

Affari 4 Scientific Society Symposium 09:45 ￫ 11:15
Endocrine disorders during pregnancy – Organized by the Hungarian Society of Gynecological Endocrinology

Chairperson/s: George Bartfai , Andras Szilagyi

Attila Jakab Adverse perinatal outcome of pregnancies after ART: twins are responsible for everything?
Szabolcs Várbíró Effect of PCOS and vitamin D deficiency and supplementation on fertility and pregnancy outcomes;
Tamás Deli Effect of endocrine disorders on fertility and fetal and maternal obstetrical outcomes
Imre Kun Tormasi Association of pathological tyrosine isoforms with parameters of hematopoiesis in
hyperfiltrating physiological pregnant women
Monika Orosz Hyperprolactinaemia in young women: treatment and follow-up of the infertile patient
Petra Merkely Gender differences in cardiovascular exercise adaptation in a rat model
Szilvia Csehely Laboratory and etiology characteristics of PCOS phenotypes

Onice Oral Presentation 09:45 ￫ 11:15
Polycystic Ovary Syndrome: obesity and metabolic syndrome impact on therapies

Chairperson/s: Blazej Meczekalski , Archil Khomasuridze

Moamar Al-Jefout Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
Maria Khmil Benefits of the use of Myo-inositol (FT 500Plus) in women with polycystic ovary syndrome undergoing in-vitro fertilization in antagonist protocols with agonist trigger to prevent the OHSS.
Meeta Meeta Performance of surrogate markers for insulin resistance in women with PCOS
Gokce Anik Ilhan Galectin-3 as a novel biomarker in women with PCOS.
Emma Öberg Improved menstrual function in obese women with polycystic ovary syndrome after behavioral modification intervention – a randomized controlled trial
Valentina Galiano Polycystic ovary syndrome (PCOS): Predictors of response to Metformin treatment
Valeria Versace The resting metabolic rate is not altered in women with polycystic ovary syndrome: a sensewear armband study.
Giovana Maffazioli Evaluation of the Impact of Low L-Carnitine Levels in Metabolic and Hormonal Profile of Polycystic Ovary Syndrome
Giulia Bonelli Classic phenotype of PCOS: does the ultrasound morphology of the ovary associate with the metabolic risk?
Georgina Carranza Escalera Frequency of Fatty Liver Disease in Polycystic Ovary Syndrome patients by phenotype A, B, C and D in the clinic of Endocrine Gynecology of the “Hospital Juárez de México”
Alina Naydukova Prediction of therapeutic effect of metformin in patients with polycystic ovary syndrome
Rodrigo Marcondes Impact of metformin and exercise, isolated or associated, on morphology and oxidative stress in adipose tissue of a polycystic ovary syndrome rat model
Vinicius Cestari do Amaral Effects of estrogen on GLUT4 and IRS1 expression in SGBS-adipocytes

Sala 4 Oral Presentation 09:45 ￫ 11:15
Quality of Life and Sexuality

Chairperson/s: Tamaki Matsumoto , Julia Savochkina

Raquel Picó Symptoms and quality of life in women of advanced age as assessed with the mrs scale.
Melinda Bartfai Measuring of quality of life and health characteristics among 40-79 old population in Hungary
Sheryl Kingsberg Bremelanotide (BMT) for Hypoactive Sexual Desire Disorder (HSDD): Efficacy Analyses from the RECONNECT Studies
Linda Vignozzi Psychological and sexual correlates of sexual abuse in women with sexual dysfunction
Linda Vignozzi Psychobiological correlates of vaginismus: an exploratory analysis
mancini ilaria Safety of 5-years testosterone treatment in Female to Male subjects
JOULEN MO-CARRASCAL Abdominal hysterectomy as a risk factor to psychological stress, alteration of sleep and quality of life
Lavinia Domenici Improving Vaginal Health And Sexual Functioning In Gynecologic Cancer Survivors With Probiotics: A Pilot Study
Maria Fernanda Mercado-Lara Comparison of quality of life in climatrics of two colombian ethnics: evaluation with scale cervantes
Angelica Monterrosa-Blanco Insomnia and sexual dysfunction associated with severe deterioration of quality of life in sexually active hysterectomys
Leidy Duran-Mendez Factors associated with sexuality disorders in menopausal colombians
Anastasia Armeni Dopamine receptor D4 (DRD4) gene and brain-derived growth factor (BDNF) gene polymorphisms enhance the impact of estrogen receptor α (ERα) gene polymorphism on female sexuality.

11:15 Saturday 10th

Break

11:45 Saturday 10th

Affari 1 Key Lecture 11:45 ￫ 12:15
Molecular pathways of ageing

Chairperson/s: Andrzej Milewicz

Bruno Lunenfeld Molecular pathways of ageing

Affari 0 Key Lecture 11:45 ￫ 12:15
Pituitary adenomas- clinical challenges

Chairperson/s: George Creatsas

Joseph Schenker Pituitary adenomas- clinical challenges

Affari 2 Key Lecture 11:45 ￫ 12:15
Significance of estrogens metabolites in the pathophysiology of PCOS

Chairperson/s: Sarah Berga

Luigi Devoto Significance of estrogens metabolites in the pathophysiology of PCOS

Verde Key Lecture 11:45 ￫ 12:15
Menopause hormone therapy after 65: available data, risks and benefits

Chairperson/s: Frederick Naftolin

Martin Birkhaeuser Menopause hormone therapy after 65: available data, risks and benefits

12:30 Saturday 10th

Affari 1 Symposium 12:30 ￫ 14:00
Post Reproductive Health

Chairperson/s: David Archer , Nestor Siseles

Margaret Rees Managing menopause and post reproductive health: beyond hormones and medicines
Cuauhtemoc Celis-Gonzalez Straw and the most frequent co-morbidities
Sandro Scattareggia, Claudia Buzzi, Andrea Giannini The development of an adaptive application to empower women into a healthy life at menopause – the Vita Nova project
Damir Franic Regenerative medicine in post-menopause

Affari 0 Symposium 12:30 ￫ 14:00
Puberty and adolescence

Chairperson/s: Efthymios Deligeoroglou , Charles Sultan

Blazej Meczekalski Kisspeptin role in functional hypothalamic amenorrhea
Camil Castelo Branco Management of transsexuality in an outpatient gynecologic area
George Creatsas Dysfunctional uterine bleeding in adolescence
Vincenzina Bruni Premature ovarian insufficiency therapy in young women

Affari 2 Symposium 12:30 ￫ 14:00
Vitamin D

Chairperson/s: Ulysse Gaspard , Ewald Boschitsch

Faustino Perez Lopez Maternal vitamin D and reproductive outcomes
Andrzej Milewicz Serum vitamine D levels and VDR polymorphisms in women with PCOS
Mark Brincat Vitamin D in PCO and endometriosis. Levels and significance
Yuliya Savochkina Vitamin D level in women with anovulatory disfunction

Verde Symposium 12:30 ￫ 14:00
Contraception: difficult cases

Chairperson/s: Johannes Bitzer , Kristina Gemzell-Danielsson

Rossella E. Nappi Hormonally-related headaches
Nilson R. De Melo Contraception in menopausal transition
Kristina Gemzell Danielsson Contraception for teenagers and young women
Peter Chedraui Contraception in women with cardiovascular risk factors

Affari 4 Oral Presentation 12:30 ￫ 14:00
Assisted Reproduction Technologies: from ovulation induction to luteal phase support

Chairperson/s: Patrizia Monteleone , Antonio La Marca

Jean Rouleau Progesterone levels higher than 1,7 ng/ml on the day of hCG are associated with lower clinical pregnancy rates in hcg-triggered gnrh antagonist cycles
Cristina Cossetti Effect of specific nutrients on ovulation, oocytes development, gene expression and coupling success in mice
Fatemehsadat Hoseini A randomized controlled trial of gonadotropinreleasing hormone agonist versus gonadotropinreleasing hormone antagonist in Iranian infertile couples: oocyte gene expression
Shabnam Fayezi Effect of oleic acid on in vitro maturation of oocytes collected from polycystic ovaries and subsequent preimplantation embryonic development
Romualdo Sciorio Blastocysts collapse as an embryo marker of low implantation potential a Time-Lapse study
Hui Long Age related nomogram of serum Anti-Mullerian hormone (AMH) and its prediction of ovarian response in female cynomolgus monkeys undergoing assisted reproductive technology treatment
Sharon Vanetik Day two post retrieval 1,500 IUI hCG bolus, progesterone-free luteal support post GnRH agonist trigger – a proof of concept study.
Hui Lim Does using the combined oral contraceptive pill for scheduling in the GnRH antagonist protocol for IVF/ICSI reduce the pregnancy rate?
Julia Bosdou Subcutaneous progesterone versus vaginal progesterone for luteal phase support in in-vitro fertilization (IVF): a systematic review and meta-analysis
Emina Ejubovic The relationship between the preovulatory and postovulatory progesterone serum concentration and the outcome of the in vitro fertilization
Mohamed Basly Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a Prospective randomised controlled trial (RCT)

Onice Oral Presentation 12:30 ￫ 14:00
Pregnancy and Labour

Chairperson/s: Stefano Luisi , Eran Hadar

Michaela dušková Maternal smoking and changes in the fetal steroidogenesis – is there difference due to sex of child?
Diptika Tiwari Detrimental effect of progesterone pathway deregulation modulated immune activation in preterm delivery and outcome in hepatitis e virus (hev) infected pregnancy cases from northeast india
Franzel Alvarez Hott Precocious pregnant teenagers treated in hospital santiago oriente dr. luis tisné brousse: epidemiological profile and perinatal outcomes.
Andrea Sepulveda Perinatal results in premature rupture of fetal membranes in pregnancies under 25 weeks, local experience
Andreas Zouridis Intauterine HPV transmission – a systematic review of the literature and meta-analysis
Muhammad Azrai Abu Is neonatal outcome of the second twin promising?
Chunfeng Yun Prevalence and social factors for birth trauma caused disability among Chinese children: A national survey
Maximilian Brincat A comprehensive literature review on the diagnosis and management of interstitial ectopic pregnancies.
Antonio Simone Laganà Effects of Micronised Dispersible Ferric Pyrophosphate combined with Alpha-Lactalbumin in pregnant women affected by Iron Deficiency Anemia: preliminary results from a prospective, double-blind, randomized controlled trial

Sala 4 Oral Presentation 12:30 ￫ 14:00
Premature Ovarian Insufficiency

Chairperson/s: Lydia Scemama , James Pickar

Iulia Potorac Fluctuating primary ovarian insufficiency in a case of type 2 autoimmune polyendocrinopathy
Asma Sassi Premature ovarian Insufficiency: a case report of a particular syndromic association
Svetlana Dragojevic Dikic POI – current hormonal approach in optimizing fertility-the role of melatonin
Anna Szeliga Bone mineral density in patients with premature ovarian insufficiency. The role of hormonal replacement therapy.
Marta Hentschke Is ovulation induction in patients with polycystic ovary syndrome associated with negative maternal outcomes?
Camila Menezes Lima Psychological evaluation in women with premature ovarian insufficiency using Hormonal therapy: depression, anxiety, and stress
Andrea Giraldo Body fat distribution in women with premature ovarian insufficiency on estroprogestative hormone therapy
Helena Giraldo Interferential current: a new treatment for lubrication and dyspareunia complaints in women with premature ovarian failure using hormone therapy

Wednesday 7th March 2018

08:30 Wednesday 7th

Affari 1 Pre-Congress Course 08:30 ￫ 13:30 Menstrual cycle disorders: from adolescence to menopause

09:00 Wednesday 7th

Sala 226 Assembly 09:00 ￫ 11:00 FISGE Meeting

11:30 Wednesday 7th

Sala 226 Assembly 11:30 ￫ 13:30 FLEG Meeting

15:30 Wednesday 7th

Auditorium Opening Symposium 15:30 ￫ 17:00 Intracrinology: the open door to the future

17:15 Wednesday 7th

Auditorium Opening Ceremony 17:15 ￫ 18:00

18:00 Wednesday 7th

Auditorium Opening Lecture 18:00 ￫ 18:30 for the Bruno Lunenfeld Lecture: RANKL – from bone loss to breast cancer (introduced by Lunenfeld Bruno)

18:30 Wednesday 7th

Auditorium Opening Lecture 18:30 ￫ 19:00 The neurological and immunological transitions of the perimenopause: implications for post menopausal neurodegenerative disease (introduced by Frederick Naftolin)

19:00 Wednesday 7th

Poster Area Poster Session 19:00 ￫ 21:00 From 1 To 176 See the posters that will be presented!

19:05 Wednesday 7th

Poster Area Poster Session 19:05 ￫ 21:00 From 177 To 365 See the posters that will be presented!

Thursday 8th March 2018

08:30 Thursday 8th

Auditorium Meet the Experts 08:30 ￫ 09:30 SPRM

Affari 1 Meet the Experts 08:30 ￫ 09:30 Bilateral oophorectomy in pre-menopausal women

Affari 0 Corso Superiore di Ginecologia Endocrinologica AIGE 08:30 ￫ 11:30 PCOS e dismetabolismo

Affari 2 Scientific Society Symposium 08:30 ￫ 09:30 Contraception: interesting aspects – Organized by the European Society of Contraception and Reproductive Health (ESC)

Verde Scientific Society Symposium 08:30 ￫ 09:30 Update in Ovarian Cancer- Organized by the Société Européenne de Langue Franco-Allemande de Gynécologie-Obstétrique (SELFAGO)

Affari 4 Scientific Society Symposium 08:30 ￫ 09:30 The Brazilian experience in Polycystic Ovary Syndrome – Organized by the Sociedade Brasileira de Ginecologia Endocrina (SOBRAGE)

Onice Scientific Society Symposium 08:30 ￫ 09:30 Panel Discussion “From Conception to delivery in Indian PCOS” – Organized by the PCOS Society of India

Sala 4 Scientific Society Symposium 08:30 ￫ 09:30 Session organized by the German Society of Gynecological Endocrinology and Reproduction (DGGEF)

09:45 Thursday 8th

Auditorium Symposium 09:45 ￫ 11:15 Premature labor: how to prevent, how to manage

Affari 1 Scientific Society Symposium 09:45 ￫ 11:15 Alliance of the surgeon and gynecologist-endocrinologist in reproductive medicine – Organized by the Russian Association of Endometriosis

Affari 2 Symposium 09:45 ￫ 11:15 ART – New therapies and new challenges: the individual factors

Verde Scientific Society Symposium 09:45 ￫ 11:15 Menopause medicine: think sexuality! – Organized by the International Menopause Society (IMS)

Affari 4 Scientific Society Symposium 09:45 ￫ 11:15 Gynecological Endocrinology and the Women Health’s future – Organized by the Asociacion Latinoamericana de Endocrinología Ginecologica (ALEG)

Onice Oral Presentation 09:45 ￫ 11:15 Amenorrhea and stress related hypothalamic disorders

Sala 4 Oral Presentation 09:45 ￫ 11:15 Endocrine disorders and other pathologies: impact on reproductive function

11:15 Thursday 8th

Break

11:45 Thursday 8th

Auditorium Symposium 11:45 ￫ 13:15 Estetrol and Breast Cancer

Affari 1 Symposium 11:45 ￫ 13:15 Urogenital aging

Affari 2 Symposium 11:45 ￫ 13:15 Reproductive impairment: from nature to therapies

Verde Symposium 11:45 ￫ 13:15 Cardiovascular protection and life long risk factors: diagnosis and management

Affari 4 Scientific Society Symposium 11:45 ￫ 13:15 Obesidad y su impacto en la salud reproductiva de la mujer – Organized by the Federacion Latina de Endocrinología Ginecologica (FLEG)

Onice Oral Presentation 11:45 ￫ 13:15 Pregnancy: abortion and recurrent pregnancy loss

Sala 4 Oral Presentation 11:45 ￫ 13:15 Assisted Reproduction Technologies: from induction of ovulation to endometrial receptivity therapies

12:00 Thursday 8th

Affari 0 Sponsored Key Lecture 12:00 ￫ 12:30

12:45 Thursday 8th

Affari 0 Sponsored Key Lecture 12:45 ￫ 13:15

13:30 Thursday 8th

Affari 1 Sponsored Lunch Symposium 13:30 ￫ 15:15

Affari 0 Sponsored Lunch Symposium 13:30 ￫ 15:15

15:15 Thursday 8th

Break

15:45 Thursday 8th

Auditorium Meet the Experts 15:45 ￫ 16:45 Should we re-think the role of gonadotrophins after the menopause?

Affari 1 Sponsored Meet the Experts 15:45 ￫ 16:45

Affari 0 Meet the Experts 15:45 ￫ 16:45 Stress and reproduction

Affari 2 Sponsored Meet the Experts 15:45 ￫ 16:45

Verde Sponsored Meet the Experts 15:45 ￫ 16:45

Affari 4 Meet the Experts 15:45 ￫ 16:45 Ovarian tumors

Onice Oral Presentation 15:45 ￫ 16:45 Endometrial Hyperplasia and Endometrial Cancer

Sala 4 Oral Presentation 15:45 ￫ 16:45 Gynecological Surgery

16:45 Thursday 8th

Auditorium Symposium 16:45 ￫ 18:15 Premature Ovarian Insufficency

Affari 1 Symposium 16:45 ￫ 18:15 Fertility preservation: possibilities and strategies

Affari 0 Symposium 16:45 ￫ 18:15 The role of exogenous sex hormones in pregnancy (Organized by the PREIS School Academy session)

Affari 2 Sponsored Symposium 16:45 ￫ 18:15

Verde Symposium 16:45 ￫ 18:15 Menopausal transition

Affari 4 Oral Presentation 16:45 ￫ 18:15 Polycystic Ovary Syndrome

Onice Oral Presentation 16:45 ￫ 18:15 Endometriosis: ethiology and pathogenesis

Sala 4 Oral Presentation 16:45 ￫ 18:15 Breast Cancer

18:15 Thursday 8th

Auditorium ISGE General Assembly 18:15 ￫ 19:30 ISGE General Assembly

Affari 1 Scholarship Course 18:15 ￫ 19:30 Scholarship Course

Friday 9th March 2018

08:30 Friday 9th

Auditorium Meet the Experts 08:30 ￫ 09:30 Progesterone and SPRMs effects on endometrium for decidualization and receptivity

Affari 1 Pre-Congress Course 08:30 ￫ 13:30
Menstrual cycle disorders: from adolescence to menopause

Sala 226 Assembly 09:00 ￫ 11:00
FISGE Meeting

Sala 226 Assembly 11:30 ￫ 13:30
FLEG Meeting

Auditorium Opening Symposium 15:30 ￫ 17:00
Intracrinology: the open door to the future

Auditorium Opening Lecture 18:00 ￫ 18:30
for the Bruno Lunenfeld Lecture: RANKL – from bone loss to breast cancer (introduced by Lunenfeld Bruno)

Auditorium Opening Lecture 18:30 ￫ 19:00
The neurological and immunological transitions of the perimenopause: implications for post menopausal neurodegenerative disease (introduced by Frederick Naftolin)

Poster Area Poster Session 19:00 ￫ 21:00
From 1 To 176 See the posters that will be presented!

Poster Area Poster Session 19:05 ￫ 21:00
From 177 To 365 See the posters that will be presented!

Auditorium Meet the Experts 08:30 ￫ 09:30
SPRM

Affari 1 Meet the Experts 08:30 ￫ 09:30
Bilateral oophorectomy in pre-menopausal women

Affari 0 Corso Superiore di Ginecologia Endocrinologica AIGE 08:30 ￫ 11:30
PCOS e dismetabolismo

Affari 2 Scientific Society Symposium 08:30 ￫ 09:30
Contraception: interesting aspects – Organized by the European Society of Contraception and Reproductive Health (ESC)

Verde Scientific Society Symposium 08:30 ￫ 09:30
Update in Ovarian Cancer- Organized by the Société Européenne de Langue Franco-Allemande de Gynécologie-Obstétrique (SELFAGO)

Affari 4 Scientific Society Symposium 08:30 ￫ 09:30
The Brazilian experience in Polycystic Ovary Syndrome – Organized by the Sociedade Brasileira de Ginecologia Endocrina (SOBRAGE)

Onice Scientific Society Symposium 08:30 ￫ 09:30
Panel Discussion “From Conception to delivery in Indian PCOS” – Organized by the PCOS Society of India

Sala 4 Scientific Society Symposium 08:30 ￫ 09:30
Session organized by the German Society of Gynecological Endocrinology and Reproduction (DGGEF)

Auditorium Symposium 09:45 ￫ 11:15
Premature labor: how to prevent, how to manage

Affari 1 Scientific Society Symposium 09:45 ￫ 11:15
Alliance of the surgeon and gynecologist-endocrinologist in reproductive medicine – Organized by the Russian Association of Endometriosis

Affari 2 Symposium 09:45 ￫ 11:15
ART – New therapies and new challenges: the individual factors

Verde Scientific Society Symposium 09:45 ￫ 11:15
Menopause medicine: think sexuality! – Organized by the International Menopause Society (IMS)

Affari 4 Scientific Society Symposium 09:45 ￫ 11:15
Gynecological Endocrinology and the Women Health’s future – Organized by the Asociacion Latinoamericana de Endocrinología Ginecologica (ALEG)

Onice Oral Presentation 09:45 ￫ 11:15
Amenorrhea and stress related hypothalamic disorders

Sala 4 Oral Presentation 09:45 ￫ 11:15
Endocrine disorders and other pathologies: impact on reproductive function

Auditorium Symposium 11:45 ￫ 13:15
Estetrol and Breast Cancer

Affari 1 Symposium 11:45 ￫ 13:15
Urogenital aging

Affari 2 Symposium 11:45 ￫ 13:15
Reproductive impairment: from nature to therapies

Verde Symposium 11:45 ￫ 13:15
Cardiovascular protection and life long risk factors: diagnosis and management

Affari 4 Scientific Society Symposium 11:45 ￫ 13:15
Obesidad y su impacto en la salud reproductiva de la mujer – Organized by the Federacion Latina de Endocrinología Ginecologica (FLEG)

Onice Oral Presentation 11:45 ￫ 13:15
Pregnancy: abortion and recurrent pregnancy loss

Sala 4 Oral Presentation 11:45 ￫ 13:15
Assisted Reproduction Technologies: from induction of ovulation to endometrial receptivity therapies

Auditorium Meet the Experts 15:45 ￫ 16:45
Should we re-think the role of gonadotrophins after the menopause?

Affari 0 Meet the Experts 15:45 ￫ 16:45
Stress and reproduction

Affari 4 Meet the Experts 15:45 ￫ 16:45
Ovarian tumors

Onice Oral Presentation 15:45 ￫ 16:45
Endometrial Hyperplasia and Endometrial Cancer

Sala 4 Oral Presentation 15:45 ￫ 16:45
Gynecological Surgery

Auditorium Symposium 16:45 ￫ 18:15
Premature Ovarian Insufficency

Affari 1 Symposium 16:45 ￫ 18:15
Fertility preservation: possibilities and strategies

Affari 0 Symposium 16:45 ￫ 18:15
The role of exogenous sex hormones in pregnancy (Organized by the PREIS School Academy session)

Verde Symposium 16:45 ￫ 18:15
Menopausal transition

Affari 4 Oral Presentation 16:45 ￫ 18:15
Polycystic Ovary Syndrome

Onice Oral Presentation 16:45 ￫ 18:15
Endometriosis: ethiology and pathogenesis

Sala 4 Oral Presentation 16:45 ￫ 18:15
Breast Cancer

Auditorium ISGE General Assembly 18:15 ￫ 19:30
ISGE General Assembly

Affari 1 Scholarship Course 18:15 ￫ 19:30
Scholarship Course

Auditorium Meet the Experts 08:30 ￫ 09:30
Progesterone and SPRMs effects on endometrium for decidualization and receptivity

Affari 1 Meet the Experts 08:30 ￫ 09:30
The vaginal and endometrial microbiota

Affari 0 Corso Superiore di Ginecologia Endocrinologica AIGE 08:30 ￫ 11:30
Management della Terapia Ormonale Sostitutiva

Affari 2 Scientific Society Symposium 08:30 ￫ 09:30
Gynecological surgery: from complications to new possibilities – Organized by the International Academy of Human Reproduction (IAHR)

Verde Scientific Society Symposium 08:30 ￫ 09:30
Hot topics in Gynecological Endocrinology – Organized by the Polish Society of Gynecological Endocrinology

Affari 4 Scientific Society Symposium 08:30 ￫ 09:30
Aspects related to middle-aged women – Organized by the Asociacion Argentina para el estudio del Climaterio (AAPEC)

Onice Scientific Society Symposium 08:30 ￫ 09:30
Male Contraception under the auspices of ICMC – Organized by the International Consortium for Male Contraception (ICMC)

Sala 4 Oral Presentation 08:30 ￫ 09:30
Gynecological Cancers

Auditorium Symposium 09:45 ￫ 11:15
Neurosteroids as regenerative agents

Affari 1 Scientific Society Symposium 09:45 ￫ 11:15
Alternative treatment methods of patients with benign tumors and hyperplastic processes of the uterus in women of reproductive age- Organized by the Russian Society of Reproductive Medicine and Surgery

Verde Symposium 09:45 ￫ 11:15
PCO: genetic, epigenetic and metabolic risk factors

Affari 4 Scientific Society Symposium 09:45 ￫ 11:15
Clinical challenges in the menopause transition – Organized by the Latino-American Federation of Climateric and Menopause Societies (FLASCYM)

Onice Scientific Society Symposium 09:45 ￫ 11:15
Role of progestogens in women’s health: an up-date – Organized by the European Progestogen Club (EPC)

Sala 4 Oral Presentation 09:45 ￫ 11:15
Menopause: vascular effects and cardiovascular diseases

Auditorium Symposium 11:45 ￫ 13:15
Neuroprotection

Affari 1 Symposium 11:45 ￫ 13:15
Androgens

Affari 2 Symposium 11:45 ￫ 13:15
Osteoporosis: a long life risk for women

Verde Symposium 11:45 ￫ 13:15
Endometriosis/Adenomyosis: from basic science to clinics

Affari 4 Scientific Society Symposium 11:45 ￫ 13:15
Management of healthy ageing – Organized by the European Menopause and Andropause Society (EMAS)

Onice Oral Presentation 11:45 ￫ 13:15
Assisted Reproduction Technologies: predictive markers, OHSS and ethical aspects

Sala 4 Oral Presentation 11:45 ￫ 13:15
Pre-Eclampsia and Pregnancy Induced Hypertension

Affari 2 Lunch Symposium 13:30 ￫ 15:15
Evolution in contraception in 2018

Auditorium Key Lecture 15:45 ￫ 16:15
Only Estrogen-Only is good for Breast Cancer

Affari 1 Key Lecture 15:45 ￫ 16:15
Endometriosis and adenomyosis in adolescents, fertile and menopausal women

Affari 0 Key Lecture 15:45 ￫ 16:15
The ovarian renin-angiotensin system

Affari 2 Key Lecture 15:45 ￫ 16:15
Current perspectives on the management of Uterine Fibroids

Verde Key Lecture 15:45 ￫ 16:15
Stress, emotional eating, and reproductive function

Auditorium Symposium 16:30 ￫ 18:00
Breast cancer: clinical impact of latest investigations

Affari 1 Symposium 16:30 ￫ 18:00
Depression and cognition in midlife women

Affari 0 Symposium 16:30 ￫ 18:00
Cardiovascular protection: the sex steroids challenges

Affari 2 Symposium 16:30 ￫ 18:00
Early pregnancy: a critical period with multiple affecting factors

Verde Symposium 16:30 ￫ 18:00
Contraception: personalized regimens, new molecules

Affari 4 Oral Presentation 16:30 ￫ 18:00
Vulvo-Vaginal Atrophy , Bone effects and other Menopause symptoms

Onice Oral Presentation 16:30 ￫ 18:00
Pregnancy: gestational diabetes mellitus

Sala 4 Oral Presentation 16:30 ￫ 18:00
Endometriosis, DUB and Uterine Fibroids: symptoms and treatments

Auditorium Symposium 18:00 ￫ 19:30
Precision medicine and hormone therapy: right woman, right time, right regimen.